| Year |
Citation |
Score |
| 2024 |
Ayyash S, Davis AD, Alders GL, MacQueen G, Strother SC, Hassel S, Zamyadi M, Arnott SR, Harris JK, Lam RW, Milev R, Müller DJ, Kennedy SH, Rotzinger S, Frey BN, et al. Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study. Ibro Neuroscience Reports. 16: 135-146. PMID 38293679 DOI: 10.1016/j.ibneur.2023.12.011 |
0.663 |
|
| 2024 |
Nogovitsyn N, Ballester P, Lasby M, Dunlop K, Ceniti AK, Squires S, Rowe J, Ho K, Suh J, Hassel S, Souza R, Casseb RF, Harris JK, Zamyadi M, Arnott SR, ... ... Kennedy SH, et al. An empirical analysis of structural neuroimaging profiles in a staging model of depression. Journal of Affective Disorders. PMID 38290583 DOI: 10.1016/j.jad.2024.01.246 |
0.824 |
|
| 2024 |
Vaccarino SR, Wang S, Rizvi SJ, Lou W, Hassel S, MacQueen GM, Ho K, Frey BN, Lam RW, Milev RV, Rotzinger S, Ravindran AV, Strother SC, Kennedy SH. Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder. Bjpsych Open. 10: e18. PMID 38179598 DOI: 10.1192/bjo.2023.588 |
0.689 |
|
| 2023 |
Mazurka R, Cunningham S, Hassel S, Foster JA, Nogovitsyn N, Fiori LM, Strother SC, Arnott SR, Frey BN, Lam RW, MacQueen GM, Milev RV, Rotzinger S, Turecki G, Kennedy SH, et al. Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 71-80. PMID 38128154 DOI: 10.1016/j.euroneuro.2023.12.003 |
0.82 |
|
| 2023 |
Rnic K, LeMoult J, Torres IJ, Chakrabarty T, Foster J, Frey BN, Harkness KL, Ho K, Li QS, Milev R, Quilty LC, Rotzinger S, Soares CN, Uher R, Kennedy SH, et al. Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report. Psychiatry Research. 330: 115606. PMID 37979318 DOI: 10.1016/j.psychres.2023.115606 |
0.612 |
|
| 2023 |
Phaterpekar T, Nunez JJ, Morton E, Liu YS, Cao B, Frey BN, Milev RV, Müller DJ, Rotzinger S, Soares CN, Taylor VH, Uher R, Kennedy SH, Lam RW. Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 85. PMID 37967350 DOI: 10.4088/JCP.23m14864 |
0.56 |
|
| 2023 |
Vairavan S, Rashidisabet H, Li QS, Ness S, Morrison RL, Soares CN, Uher R, Frey BN, Lam RW, Kennedy SH, Trivedi M, Drevets WC, Narayan VA. Personalized relapse prediction in patients with major depressive disorder using digital biomarkers. Scientific Reports. 13: 18596. PMID 37903878 DOI: 10.1038/s41598-023-44592-8 |
0.564 |
|
| 2023 |
Rowe J, Poppenk J, Squires S, Mazurka R, Nogovitsyn N, Hassel S, Zamyadi M, Arnott SR, Rotzinger S, Kennedy SH, Milev RV, Harkness KL. Anxious arousal predicts within-person changes in hippocampal volume in adults with a history of childhood maltreatment: A CAN-BIND4 report. Journal of Psychopathology and Clinical Science. 132: 797-807. PMID 37843538 DOI: 10.1037/abn0000864 |
0.769 |
|
| 2023 |
Islam F, Magarbeh L, Elsheikh SSM, Kloiber S, Espinola CW, Bhat V, Frey BN, Milev R, Soares CN, Parikh SV, Placenza F, Hassel S, Taylor VH, Leri F, Blier P, ... ... Kennedy SH, et al. Influence of , , and Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231203433. PMID 37796764 DOI: 10.1177/07067437231203433 |
0.74 |
|
| 2023 |
Schwartzmann B, Dhami P, Uher R, Lam RW, Frey BN, Milev R, Müller DJ, Blier P, Soares CN, Parikh SV, Turecki G, Foster JA, Rotzinger S, Kennedy SH, Farzan F. Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication. Jama Network Open. 6: e2336094. PMID 37768659 DOI: 10.1001/jamanetworkopen.2023.36094 |
0.521 |
|
| 2023 |
Slyepchenko A, Uher R, Ho K, Hassel S, Matthews C, Lukus PK, Daros AR, Minarik A, Placenza F, Li QS, Rotzinger S, Parikh SV, Foster JA, Turecki G, Müller DJ, ... ... Kennedy SH, et al. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study. Scientific Reports. 13: 15300. PMID 37714910 DOI: 10.1038/s41598-023-42138-6 |
0.432 |
|
| 2023 |
McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412. PMID 37713549 DOI: 10.1002/wps.21120 |
0.339 |
|
| 2023 |
Jalali S, Liu L, Wang J, Kennedy SH, MacQueen G, Lebel C, Goldstein BL, Bray S, Addington J. Factors Associated with Transition to Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231195959. PMID 37606525 DOI: 10.1177/07067437231195959 |
0.629 |
|
| 2023 |
Nunez JJ, Liu YS, Cao B, Frey BN, Ho K, Milev R, Müller DJ, Rotzinger S, Soares CN, Taylor VH, Uher R, Kennedy SH, Lam RW. Response trajectories during escitalopram treatment of patients with major depressive disorder. Psychiatry Research. 327: 115361. PMID 37523890 DOI: 10.1016/j.psychres.2023.115361 |
0.564 |
|
| 2023 |
Lin R, Kos A, Lopez JP, Dine J, Fiori LM, Yang J, Ben-Efraim Y, Aouabed Z, Ibrahim P, Mitsuhashi H, Wong TP, Ibrahim EC, Belzung C, Blier P, Farzan F, ... ... Kennedy SH, et al. induces glutamatergic signaling following treatment with monoaminergic antidepressants. Elife. 12. PMID 37432876 DOI: 10.7554/eLife.85316 |
0.575 |
|
| 2023 |
Vaccarino AL, Black SE, Gilbert Evans S, Frey BN, Javadi M, Kennedy SH, Lam B, Lam RW, Lasalandra B, Martens E, Masellis M, Milev R, Mitchell S, Munoz DP, Sparks A, et al. Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders. Frontiers in Psychiatry. 14: 1154519. PMID 37333922 DOI: 10.3389/fpsyt.2023.1154519 |
0.587 |
|
| 2023 |
Schwartzmann B, Quilty LC, Dhami P, Uher R, Allen TA, Kloiber S, Lam RW, Frey BN, Milev R, Müller DJ, Soares CN, Foster JA, Rotzinger S, Kennedy SH, Farzan F. Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study. Scientific Reports. 13: 8418. PMID 37225718 DOI: 10.1038/s41598-023-35179-4 |
0.566 |
|
| 2023 |
Husain MI, Foster JA, Mason BL, Chen S, Zhao H, Wang W, Rotzinger S, Rizvi S, Ho K, Lam R, MacQueen G, Milev R, Frey BN, Müller D, Turecki G, ... ... Kennedy SH, et al. Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. Cns Spectrums. 1-28. PMID 37218291 DOI: 10.1017/S109285292300233X |
0.681 |
|
| 2023 |
Demchenko I, Desai N, Iwasa SN, Gholamali Nezhad F, Zariffa J, Kennedy SH, Rule NO, Cohn JF, Popovic MR, Mulsant BH, Bhat V. Manipulating facial musculature with functional electrical stimulation as an intervention for major depressive disorder: a focused search of literature for a proposal. Journal of Neuroengineering and Rehabilitation. 20: 64. PMID 37193985 DOI: 10.1186/s12984-023-01187-8 |
0.818 |
|
| 2023 |
Demchenko I, Tassone VK, Dunnett S, Balachandar A, Li S, Anderson M, Daskalakis ZJ, Foley K, Karkouti K, Kennedy SH, Ladha KS, Robertson J, Vaisman A, Koczerginski D, Parikh SV, et al. Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic. Bmc Psychiatry. 23: 327. PMID 37165333 DOI: 10.1186/s12888-023-04832-7 |
0.789 |
|
| 2023 |
Dama M, Wu M, Tassone VK, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report. Psychiatry Research. 325: 115222. PMID 37163883 DOI: 10.1016/j.psychres.2023.115222 |
0.815 |
|
| 2023 |
Chin Fatt CR, Asbury S, Jha MK, Minhajuddin A, Sethuram S, Mayes T, Kennedy SH, Foster JA, Trivedi MH. Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study. Translational Psychiatry. 13: 139. PMID 37117195 DOI: 10.1038/s41398-023-02416-3 |
0.377 |
|
| 2023 |
Harkness KL, Chakrabarty T, Rizvi SJ, Mazurka R, Quilty L, Uher R, Milev RV, Frey BN, Parikh SV, Foster JA, Rotzinger S, Kennedy SH, Lam RW. The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231156255. PMID 36785892 DOI: 10.1177/07067437231156255 |
0.502 |
|
| 2023 |
Fu CHY, Erus G, Fan Y, Antoniades M, Arnone D, Arnott SR, Chen T, Choi KS, Fatt CC, Frey BN, Frokjaer VG, Ganz M, Garcia J, Godlewska BR, Hassel S, ... ... Kennedy SH, et al. AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale. Bmc Psychiatry. 23: 59. PMID 36690972 DOI: 10.1186/s12888-022-04509-7 |
0.596 |
|
| 2023 |
Magarbeh L, Hassel C, Choi M, Islam F, Marshe VS, Zai CC, Zuberi R, Gammal RS, Men X, Scherf-Clavel M, Enko D, Frey BN, Milev R, Soares CN, Parikh SV, ... ... Kennedy SH, et al. ABCB1 gene variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-analysis including results from the CAN-BIND-1 Study. Clinical Pharmacology and Therapeutics. PMID 36681895 DOI: 10.1002/cpt.2854 |
0.493 |
|
| 2023 |
Ballester PL, Suh JS, Ho NCW, Liang L, Hassel S, Strother SC, Arnott SR, Minuzzi L, Sassi RB, Lam RW, Milev R, Müller DJ, Taylor VH, Kennedy SH, Reilly JP, et al. Gray matter volume drives the brain age gap in schizophrenia: a SHAP study. Schizophrenia (Heidelberg, Germany). 9: 3. PMID 36624107 DOI: 10.1038/s41537-022-00330-z |
0.45 |
|
| 2022 |
Ali M, Suh JS, Ramonas M, Hassel S, Arnott SR, Strother SC, Minuzzi L, Sassi RB, Lam RW, Milev R, Müller DJ, Taylor VH, Kennedy SH, Frey BN. A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI. Methodsx. 9: 101864. PMID 36193115 DOI: 10.1016/j.mex.2022.101864 |
0.395 |
|
| 2022 |
Metzak PD, Shakeel MK, Long X, Lasby M, Souza R, Bray S, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Addington J, Lebel C. Brain connectomes in youth at risk for serious mental illness: an exploratory analysis. Bmc Psychiatry. 22: 611. PMID 36109720 DOI: 10.1186/s12888-022-04118-4 |
0.576 |
|
| 2022 |
Islam F, Marshe VS, Magarbeh L, Frey BN, Milev RV, Soares CN, Parikh SV, Placenza F, Strother SC, Hassel S, Taylor VH, Leri F, Blier P, Uher R, Farzan F, ... ... Kennedy SH, et al. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study. Translational Psychiatry. 12: 366. PMID 36068210 DOI: 10.1038/s41398-022-02124-4 |
0.47 |
|
| 2022 |
Sajjadian M, Uher R, Ho K, Hassel S, Milev R, Frey BN, Farzan F, Blier P, Foster JA, Parikh SV, Müller DJ, Rotzinger S, Soares CN, Turecki G, Taylor VH, ... ... Kennedy SH, et al. Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. Psychological Medicine. 1-11. PMID 36004538 DOI: 10.1017/S0033291722002124 |
0.589 |
|
| 2022 |
Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenwaym KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221111371. PMID 35975555 DOI: 10.1177/07067437221111371 |
0.61 |
|
| 2022 |
Harris JK, Hassel S, Davis AD, Zamyadi M, Arnott SR, Milev R, Lam RW, Frey BN, Hall GB, Müller DJ, Rotzinger S, Kennedy SH, Strother SC, MacQueen GM, Greiner R. Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report. Neuroimage. Clinical. 35: 103120. PMID 35908308 DOI: 10.1016/j.nicl.2022.103120 |
0.652 |
|
| 2022 |
Kim HK, Zai G, Müller DJ, Husain MI, Lam RW, Frey BN, Soares CN, Parikh SV, Milev R, Foster JA, Turecki G, Farzan F, Mulsant BH, Kennedy SH, Tripathy SJ, et al. Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. Pharmacopsychiatry. PMID 35793696 DOI: 10.1055/a-1872-0844 |
0.62 |
|
| 2022 |
Lin J, Su Y, Rizvi SJ, Jagoda J, Li J, Wu Y, Dai Y, Zhang Y, Kennedy SH, Si T. Define and characterize the anhedonia in major depressive disorder: An explorative study. Journal of Affective Disorders. PMID 35788366 DOI: 10.1016/j.jad.2022.06.082 |
0.404 |
|
| 2022 |
Hicks O, McInerney SJ, Lam RW, Milev RV, Frey BN, Soares CN, Foster JA, Rotzinger S, Kennedy SH, Harkness KL. Acute and chronic stress predict anti-depressant treatment outcome and naturalistic course of major depression: A CAN-BIND report. Journal of Affective Disorders. PMID 35760190 DOI: 10.1016/j.jad.2022.06.058 |
0.55 |
|
| 2022 |
Demchenko I, Tassone VK, Kennedy SH, Dunlop K, Bhat V. Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review. Frontiers in Psychiatry. 13: 864902. PMID 35722550 DOI: 10.3389/fpsyt.2022.864902 |
0.814 |
|
| 2022 |
Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221099769. PMID 35711159 DOI: 10.1177/07067437221099769 |
0.682 |
|
| 2022 |
Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report. Journal of Psychopharmacology (Oxford, England). 2698811221095832. PMID 35546043 DOI: 10.1177/02698811221095832 |
0.826 |
|
| 2022 |
Diep C, Rosenek N, Khoo Y, Gandhi W, van Reekum CM, Ravindran AV, Ladha KS, Frey BN, Milev RV, Rotzinger S, Lam RW, Kennedy SH, Lou W, Salomons T, Bhat V. Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report. Psychiatry Research. 312: 114557. PMID 35461118 DOI: 10.1016/j.psychres.2022.114557 |
0.713 |
|
| 2022 |
Mosabbir AA, Braun Janzen T, Al Shirawi M, Rotzinger S, Kennedy SH, Farzan F, Meltzer J, Bartel L. Investigating the Effects of Auditory and Vibrotactile Rhythmic Sensory Stimulation on Depression: An EEG Pilot Study. Cureus. 14: e22557. PMID 35371676 DOI: 10.7759/cureus.22557 |
0.357 |
|
| 2022 |
Liu H, Kerzner J, Demchenko I, Wijeysundera DN, Kennedy SH, Ladha KS, Bhat V. Nitrous Oxide for the Treatment of Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape. Acta Psychiatrica Scandinavica. PMID 35353901 DOI: 10.1111/acps.13432 |
0.789 |
|
| 2022 |
Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and Behavior. e2555. PMID 35333448 DOI: 10.1002/brb3.2555 |
0.831 |
|
| 2022 |
Kennedy SH. Beyond Response: Aiming for Quality Remission in Depression. Advances in Therapy. 39: 20-28. PMID 35247185 DOI: 10.1007/s12325-021-02030-z |
0.324 |
|
| 2022 |
Vaccarino AL, Beaton D, Black SE, Blier P, Farzan F, Finger E, Foster JA, Freedman M, Frey BN, Gilbert Evans S, Ho K, Javadi M, Kennedy SH, Lam RW, Lang AE, et al. Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders. Frontiers in Psychiatry. 13: 816465. PMID 35197877 DOI: 10.3389/fpsyt.2022.816465 |
0.471 |
|
| 2022 |
Elias GJB, Germann J, Loh A, Boutet A, Pancholi A, Beyn ME, Bhat V, Woodside DB, Giacobbe P, Kennedy SH, Lozano AM. Habenular Involvement in Response to Subcallosal Cingulate Deep Brain Stimulation for Depression. Frontiers in Psychiatry. 13: 810777. PMID 35185654 DOI: 10.3389/fpsyt.2022.810777 |
0.696 |
|
| 2022 |
Nogovitsyn N, Metzak PD, Casseb RF, Souza R, Harris JK, Prati LM, Zamyadi M, Bray SL, Lebel C, Hassel S, Strother S, Goldstein BI, Wang J, Kennedy SH, MacQueen GM, et al. Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis. Schizophrenia Research. 240: 220-227. PMID 35074702 DOI: 10.1016/j.schres.2021.12.041 |
0.803 |
|
| 2022 |
Dhami P, Quilty LC, Schwartzmann B, Uher R, Allen TA, Kloiber S, Lam RW, MacQueen G, Frey BN, Milev R, Müller DJ, Strother SC, Blier P, Soares CN, Parikh SV, ... ... Kennedy SH, et al. Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A CAN-BIND Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 35032682 DOI: 10.1016/j.bpsc.2021.12.012 |
0.664 |
|
| 2022 |
Anteraper SA, Guell X, Lee YJ, Raya J, Demchenko I, Churchill NW, Frey BN, Hassel S, Lam RW, MacQueen GM, Milev R, Schweizer TA, Strother SC, Whitfield-Gabrieli S, Kennedy SH, et al. Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study Report. Cerebellum (London, England). PMID 35023065 DOI: 10.1007/s12311-021-01353-5 |
0.817 |
|
| 2022 |
Ceniti AK, Abdelmoemin WR, Ho K, Kang Y, Placenza F, Laframboise R, Bhat V, Foster JA, Frey BN, Lam RW, Milev R, Rotzinger S, Soares CN, Uher R, Kennedy SH. "One Degree of Separation": A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211070656. PMID 34986035 DOI: 10.1177/07067437211070656 |
0.652 |
|
| 2022 |
Vaccarino SR, Adamsahib F, Milev RV, Parikh SV, Lam RW, Blier P, Kennedy SH, Ladha KS, Bhat V. The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic Review. The Journal of Clinical Psychiatry. 83. PMID 34985832 DOI: 10.4088/JCP.21r13870 |
0.713 |
|
| 2021 |
Sajjadian M, Lam RW, Milev R, Rotzinger S, Frey BN, Soares CN, Parikh SV, Foster JA, Turecki G, Müller DJ, Strother SC, Farzan F, Kennedy SH, Uher R. Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis. Psychological Medicine. 51: 2742-2751. PMID 35575607 DOI: 10.1017/S0033291721003871 |
0.531 |
|
| 2021 |
Davis AD, Hassel S, Arnott SR, Hall GB, Harris JK, Zamyadi M, Downar J, Frey BN, Lam RW, Kennedy SH, Strother SC. Biophysical compartment models for single-shell diffusion MRI in the human brain: a model fitting comparison. Physics in Medicine and Biology. PMID 34965517 DOI: 10.1088/1361-6560/ac46de |
0.391 |
|
| 2021 |
Khoo Y, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Baseline Anxiety, and Early Anxiety/Depression Improvement in Anxious Depression Predicts Treatment Outcomes with Escitalopram: A CAN-BIND-1 Study Report. Journal of Affective Disorders. PMID 34921820 DOI: 10.1016/j.jad.2021.12.027 |
0.836 |
|
| 2021 |
Elias GJB, Germann J, Boutet A, Loh A, Li B, Pancholi A, Beyn ME, Naheed A, Bennett N, Pinto J, Bhat V, Giacobbe P, Woodside DB, Kennedy SH, Lozano AM. 3 T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation. Brain : a Journal of Neurology. PMID 34919630 DOI: 10.1093/brain/awab447 |
0.623 |
|
| 2021 |
Kerzner J, Liu H, Demchenko I, Sussman D, Wijeysundera DN, Kennedy SH, Ladha KS, Bhat V. Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape. Chronic Stress (Thousand Oaks, Calif.). 5: 24705470211055176. PMID 34901677 DOI: 10.1177/24705470211055176 |
0.811 |
|
| 2021 |
Liang S, Beaton D, Arnott SR, Gee T, Zamyadi M, Bartha R, Symons S, MacQueen GM, Hassel S, Lerch JP, Anagnostou E, Lam RW, Frey BN, Milev R, Müller DJ, ... Kennedy SH, et al. Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach. Frontiers in Neuroinformatics. 15: 622951. PMID 34867254 DOI: 10.3389/fninf.2021.622951 |
0.546 |
|
| 2021 |
Ballester PL, Suh JS, Nogovitsyn N, Hassel S, Strother SC, Arnott SR, Minuzzi L, Sassi RB, Lam RW, Milev R, Müller DJ, Taylor VH, Kennedy SH, Frey BN. Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report. Neuroimage. Clinical. 32: 102864. PMID 34710675 DOI: 10.1016/j.nicl.2021.102864 |
0.824 |
|
| 2021 |
Rnic K, Jung YE, Torres I, Chakrabarty T, LeMoult J, Vaccarino AL, Morton E, Bhat V, Giacobbe P, McInerney S, Frey BN, Milev RV, Müller D, Ravindran AV, Rotzinger S, ... Kennedy SH, et al. Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report. Journal of Affective Disorders. 295: 1095-1101. PMID 34706420 DOI: 10.1016/j.jad.2021.09.002 |
0.732 |
|
| 2021 |
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vasquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, ... ... Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disorders. PMID 34599629 DOI: 10.1111/bdi.13135 |
0.541 |
|
| 2021 |
Blumberger DM, Vila-Rodriguez F, Wang W, Knyahnytska Y, Butterfield M, Noda Y, Yariv S, Isserles M, Voineskos D, Ainsworth NJ, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J. A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression: A canadian rTMS treatment and biomarker network in depression (CARTBIND) study. Brain Stimulation. PMID 34560319 DOI: 10.1016/j.brs.2021.09.003 |
0.338 |
|
| 2021 |
Demchenko I, Blumberger DM, Flint AJ, Anderson M, Daskalakis ZJ, Foley K, Karkouti K, Kennedy SH, Ladha KS, Robertson J, Vaisman A, Koczerginski D, Parikh SV, Bhat V. Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National Survey. The Journal of Ect. PMID 34519681 DOI: 10.1097/YCT.0000000000000801 |
0.764 |
|
| 2021 |
Ballester PL, Romano MT, de A Cardoso T, Hassel S, Strother SC, Kennedy SH, Frey BN. Brain age in mood and psychotic disorders: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica. PMID 34510423 DOI: 10.1111/acps.13371 |
0.487 |
|
| 2021 |
Yrondi A, Fiori LM, Nogovitsyn N, Hassel S, Théroux JF, Aouabed Z, Frey BN, Lam RW, Milev R, Müller DJ, Foster JA, Soares C, Rotzinger S, Strother SC, MacQueen GM, ... ... Kennedy SH, et al. Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report. Translational Psychiatry. 11: 469. PMID 34508068 DOI: 10.1038/s41398-021-01592-4 |
0.796 |
|
| 2021 |
Elias GJB, Boutet A, Parmar R, Wong EHY, Germann J, Loh A, Paff M, Pancholi A, Gwun D, Kin CTCB, Gouveia FV, Harmsen IE, Beyn ME, Santarnecchi E, Fasano A, ... ... Kennedy SH, et al. Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape. Brain Stimulation. PMID 34461326 DOI: 10.1016/j.brs.2021.08.021 |
0.63 |
|
| 2021 |
Fiori LM, Orri M, Aouabed Z, Théroux JF, Lin R, Nagy C, Frey BN, Lam RW, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Uher R, Foster JA, ... Kennedy SH, et al. Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Translational Psychiatry. 11: 439. PMID 34420030 DOI: 10.1038/s41398-021-01564-8 |
0.669 |
|
| 2021 |
Jones BDM, Levitan RD, Wang W, Uher R, Rotzinger S, Foster JA, Kennedy SH, Farzan F, Quilty LC, Kloiber S. Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study. Journal of Psychiatric Research. 142: 321-327. PMID 34419752 DOI: 10.1016/j.jpsychires.2021.07.031 |
0.352 |
|
| 2021 |
van der Wijk G, Harris JK, Hassel S, Davis AD, Zamyadi M, Arnott SR, Milev R, Lam RW, Frey BN, Hall GB, Müller DJ, Rotzinger S, Kennedy SH, Strother SC, MacQueen GM, et al. Baseline Functional Connectivity in Resting State Networks Associated with Depression and Remission Status after 16 Weeks of Pharmacotherapy: A CAN-BIND Report. Cerebral Cortex (New York, N.Y. : 1991). PMID 34416758 DOI: 10.1093/cercor/bhab286 |
0.687 |
|
| 2021 |
Elias GJB, Germann J, Boutet A, Pancholi A, Beyn ME, Bhatia K, Neudorfer C, Loh A, Rizvi SJ, Bhat V, Giacobbe P, Woodside DB, Kennedy SH, Lozano AM. Structuro-functional surrogates of response to subcallosal cingulate deep brain stimulation for depression. Brain : a Journal of Neurology. PMID 34324658 DOI: 10.1093/brain/awab284 |
0.662 |
|
| 2021 |
Ayyash S, Davis AD, Alders GL, MacQueen G, Strother SC, Hassel S, Zamyadi M, Arnott SR, Harris JK, Lam RW, Milev R, Müller DJ, Kennedy SH, Rotzinger S, Frey BN, et al. Exploring brain connectivity changes in major depressive disorder using functional-structural data fusion: A CAN-BIND-1 study. Human Brain Mapping. PMID 34296501 DOI: 10.1002/hbm.25590 |
0.66 |
|
| 2021 |
Caspani G, Turecki G, Lam RW, Milev RV, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Kennedy SH, Foster JA, Swann JR. Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report. Communications Biology. 4: 903. PMID 34294869 DOI: 10.1038/s42003-021-02421-6 |
0.677 |
|
| 2021 |
Suh JS, Fiori LM, Ali M, Harkness KL, Ramonas M, Minuzzi L, Hassel S, Strother SC, Zamyadi M, Arnott SR, Farzan F, Foster JA, Lam RW, MacQueen GM, Milev R, ... ... Kennedy SH, et al. Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132: 105348. PMID 34229186 DOI: 10.1016/j.psyneuen.2021.105348 |
0.673 |
|
| 2021 |
Nunez JJ, Nguyen TT, Zhou Y, Cao B, Ng RT, Chen J, Frey BN, Milev R, Müller DJ, Rotzinger S, Soares CN, Uher R, Kennedy SH, Lam RW. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. Plos One. 16: e0253023. PMID 34181661 DOI: 10.1371/journal.pone.0253023 |
0.582 |
|
| 2021 |
Allen TA, Harkness KL, Lam RW, Milev R, Frey BN, Mueller DJ, Uher R, Kennedy SH, Quilty LC. Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report. Personality and Mental Health. PMID 34008342 DOI: 10.1002/pmh.1514 |
0.529 |
|
| 2021 |
Shakeel MK, Hassel S, Davis AD, Metzak PD, MacQueen GM, Arnott SR, Bray S, Frey BN, Goldstein BI, Hall GB, Harris J, Lam RW, MacIntosh BJ, Milev R, Mueller DJ, ... ... Kennedy SH, et al. White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research. Neuroimaging. 312: 111289. PMID 33910139 DOI: 10.1016/j.pscychresns.2021.111289 |
0.679 |
|
| 2021 |
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, McInerney S, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. Cns Drugs. 35: 439-450. PMID 33860922 DOI: 10.1007/s40263-021-00803-2 |
0.766 |
|
| 2021 |
Theyers AE, Zamyadi M, O'Reilly M, Bartha R, Symons S, MacQueen GM, Hassel S, Lerch JP, Anagnostou E, Lam RW, Frey BN, Milev R, Müller DJ, Kennedy SH, Scott CJM, et al. Multisite Comparison of MRI Defacing Software Across Multiple Cohorts. Frontiers in Psychiatry. 12: 617997. PMID 33716819 DOI: 10.3389/fpsyt.2021.617997 |
0.567 |
|
| 2021 |
Chakrabarty T, McInerney SJ, Torres IJ, Frey BN, Milev RV, Müller DJ, Rotzinger S, Kennedy SH, Lam RW. Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Cns Drugs. PMID 33683582 DOI: 10.1007/s40263-021-00793-1 |
0.552 |
|
| 2021 |
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. PMID 33652477 DOI: 10.1055/a-1385-0263 |
0.759 |
|
| 2021 |
Marshe VS, Maciukiewicz M, Hauschild AC, Islam F, Qin L, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Flint AJ, Turecki G, Lam RW, Milev RV, Frey BN, Rotzinger S, ... ... Kennedy SH, et al. Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry. 11: 127. PMID 33589590 DOI: 10.1038/s41398-021-01248-3 |
0.518 |
|
| 2021 |
Rybak YE, Lai KSP, Ramasubbu R, Blumberger DM, Chan P, Delva N, Giacobbe P, Gosselin C, Kennedy SH, Iskandar H, McInerney S, Ravitz P, Sharma V, Zaretsky A, Burhan AM. Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment. Depression and Anxiety. PMID 33528865 DOI: 10.1002/da.23135 |
0.324 |
|
| 2021 |
Farris MS, Braun A, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Addington J. Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720988450. PMID 33464130 DOI: 10.1177/0706743720988450 |
0.569 |
|
| 2020 |
Vaccarino AL, Kalali AH, Blier P, Gilbert Evans S, Engelhardt N, Foster JA, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Müller DJ, Parikh SV, Placenza FM, ... ... Kennedy SH, et al. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial. Innovations in Clinical Neuroscience. 17: 30-40. PMID 33520402 |
0.65 |
|
| 2020 |
McInerney SJ, Chakrabarty T, Maciukiewicz M, Frey BN, MacQueen GM, Milev RV, Ravindran AV, Rotzinger S, Kennedy SH, Lam RW. Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720974823. PMID 33353384 DOI: 10.1177/0706743720974823 |
0.681 |
|
| 2020 |
Ge R, Hassel S, Arnott SR, Davis AD, Harris JK, Zamyadi M, Milev R, Frey BN, Strother SC, Müller DJ, Rotzinger S, MacQueen GM, Kennedy SH, Lam RW, Vila-Rodriguez F. Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110194. PMID 33296696 DOI: 10.1016/j.pnpbp.2020.110194 |
0.686 |
|
| 2020 |
Metzak PD, Addington J, Hassel S, Goldstein BI, MacIntosh BJ, Lebel C, Wang JL, Kennedy SH, MacQueen GM, Bray S. Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study. Early Intervention in Psychiatry. PMID 33295151 DOI: 10.1111/eip.13078 |
0.57 |
|
| 2020 |
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-20. PMID 33289425 DOI: 10.1080/15622975.2020.1851052 |
0.417 |
|
| 2020 |
Swainson J, McGirr A, Blier P, Brietzke E, Richard-Devantoy S, Ravindran N, Blier J, Beaulieu S, Frey BN, Kennedy SH, McIntyre RS, Milev RV, Parikh SV, Schaffer A, Taylor VH, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720970860. PMID 33174760 DOI: 10.1177/0706743720970860 |
0.573 |
|
| 2020 |
Addington J, Liu L, Farris MS, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, MacQueen G. Clinical staging for youth at-risk for serious mental illness: A longitudinal perspective. Early Intervention in Psychiatry. PMID 33037783 DOI: 10.1111/eip.13062 |
0.57 |
|
| 2020 |
Larsen KG, Kennedy SH, Reines EH, Thase ME. Patient Response Trajectories in Major Depressive Disorder. Psychopharmacology Bulletin. 50: 8-28. PMID 33012870 |
0.347 |
|
| 2020 |
Nogovitsyn N, Addington J, Souza R, Placsko TJ, Stowkowy J, Wang J, Goldstein BI, Bray S, Lebel C, Taylor VH, Kennedy SH, MacQueen G. Childhood trauma and amygdala nuclei volumes in youth at risk for mental illness. Psychological Medicine. 1-8. PMID 32940197 DOI: 10.1017/S0033291720003177 |
0.775 |
|
| 2020 |
Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G, Parikh SV, Milev R, MacQueen G, Lam RW, Kennedy SH, et al. Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 81. PMID 32558407 DOI: 10.4088/Jcp.20M13229 |
0.685 |
|
| 2020 |
Shakeel MK, MacQueen G, Addington J, Metzak PD, Georgopoulos G, Bray S, Goldstein BI, MacIntosh BJ, Wang J, Kennedy SH, Lebel C. White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis. Psychiatry Research. Neuroimaging. 302: 111106. PMID 32505905 DOI: 10.1016/J.Pscychresns.2020.111106 |
0.608 |
|
| 2020 |
Farris MS, Shakeel MK, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Substance use in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32500614 DOI: 10.1111/Eip.12995 |
0.597 |
|
| 2020 |
Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R, Moazamigoudarzi Z, Placenza FM, Richard-Devantoy S, Rotzinger S, Turecki G, ... ... Kennedy SH, et al. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Bmc Psychiatry. 20: 268. PMID 32487236 DOI: 10.1186/S12888-020-02672-3 |
0.738 |
|
| 2020 |
Lim B, Sproule BA, Zahra Z, Sunderji N, Kennedy SH, Rizvi SJ. Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology. International Clinical Psychopharmacology. PMID 32459725 DOI: 10.1097/Yic.0000000000000316 |
0.479 |
|
| 2020 |
Dunlop K, Rizvi SJ, Kennedy SH, Hassel S, Strother SC, Harris JK, Zamyadi M, Arnott SR, Davis AD, Mansouri F, Schulze L, Ceniti AK, Lam RW, Milev R, Rotzinger S, et al. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32349119 DOI: 10.1038/S41386-020-0688-X |
0.705 |
|
| 2020 |
Rosenblat JD, Mansur RB, Brietzke E, Kennedy SH, Carvalho AF, Lee Y, Subramaniapillai M, Muzina DJ, Dale R, Tamura JK, Lui LMW, Park C, Phan L, Tuineag RM, McIntyre RS. Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders. Psychiatry Research. 288: 112967. PMID 32339805 DOI: 10.1016/J.Psychres.2020.112967 |
0.394 |
|
| 2020 |
Belzeaux R, Gorgievski V, Fiori LM, Lopez JP, Grenier J, Lin R, Nagy C, Ibrahim EC, Gascon E, Courtet P, Richard-Devantoy S, Berlim M, Chachamovich E, Théroux JF, Dumas S, ... ... Kennedy SH, et al. GPR56/ADGRG1 is associated with response to antidepressant treatment. Nature Communications. 11: 1635. PMID 32242018 DOI: 10.1038/S41467-020-15423-5 |
0.473 |
|
| 2020 |
Vallati M, Cunningham S, Mazurka R, Stewart JG, Larocque C, Milev RV, Bagby RM, Kennedy SH, Harkness KL. Childhood maltreatment and the clinical characteristics of major depressive disorder in adolescence and adulthood. Journal of Abnormal Psychology. PMID 32237880 DOI: 10.1037/Abn0000521 |
0.473 |
|
| 2020 |
Suh JS, Minuzzi L, Raamana PR, Davis A, Hall GB, Harris J, Hassel S, Zamyadi M, Arnott SR, Alders GL, Sassi RB, Milev R, Lam RW, MacQueen GM, Strother SC, ... Kennedy SH, et al. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report. Neuroimage. Clinical. 25: 102178. PMID 32036277 DOI: 10.1016/J.Nicl.2020.102178 |
0.701 |
|
| 2020 |
Nogovitsyn N, Souza R, Muller M, Srajer A, Metzak PD, Hassel S, Ismail Z, Protzner A, Bray SL, Lebel C, MacIntosh BJ, Goldstein BI, Wang J, Kennedy SH, Addington J, et al. Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry and Clinical Neurosciences. PMID 32003517 DOI: 10.1111/Pcn.12985 |
0.779 |
|
| 2020 |
Marshe VS, Islam F, Maciukiewicz M, Fiori LM, Yerko V, Yang J, Turecki G, Foster JA, Kennedy SH, Blumberger DM, Karp JF, Kennedy JL, Mulsant BH, Reynolds CF, Lenze EJ, et al. Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109867. PMID 31954757 DOI: 10.1016/J.Pnpbp.2020.109867 |
0.369 |
|
| 2020 |
Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Personality and risk for serious mental illness. Early Intervention in Psychiatry. PMID 31910491 DOI: 10.1111/Eip.12921 |
0.609 |
|
| 2020 |
Zhdanov A, Atluri S, Wong W, Vaghei Y, Daskalakis ZJ, Blumberger DM, Frey BN, Giacobbe P, Lam RW, Milev R, Mueller DJ, Turecki G, Parikh SV, Rotzinger S, Soares CN, ... ... Kennedy SH, et al. Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. Jama Network Open. 3: e1918377. PMID 31899530 DOI: 10.1001/jamanetworkopen.2019.18377 |
0.569 |
|
| 2020 |
Stowkowy J, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Trauma in Youth At-Risk for Serious Mental Illness. The Journal of Nervous and Mental Disease. 208: 70-76. PMID 31834192 DOI: 10.1097/Nmd.0000000000001069 |
0.635 |
|
| 2020 |
Dunlop K, Rizvi S, Hassel S, Strother SC, Lam RW, Milev R, Rotzinger S, Frey BN, Parikh S, Soares C, Uher R, Turecki G, MacQueen G, Kennedy SH, Liston C. Pre-Treatment Resting-State Functional Connectivity Related to Anhedonia and Anxiety are Associated With Antidepressant Response to Escitalopram and Adjunct Aripiprazole Biological Psychiatry. 87: S431. DOI: 10.1016/J.Biopsych.2020.02.1098 |
0.666 |
|
| 2019 |
Daniels S, Horman T, Lapointe T, Melanson B, Storace A, Kennedy SH, Frey BN, Rizvi SJ, Hassel S, Mueller DJ, Parikh SV, Lam RW, Blier P, Farzan F, Giacobbe P, et al. Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. Journal of Affective Disorders. 263: 353-366. PMID 31969265 DOI: 10.1016/J.Jad.2019.11.108 |
0.646 |
|
| 2019 |
Yrondi A, Fiori LM, Frey BN, Lam RW, MacQueen GM, Milev R, Müller DJ, Foster JA, Kennedy SH, Turecki G. Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report. The International Journal of Neuropsychopharmacology. PMID 31819986 DOI: 10.1093/Ijnp/Pyz066 |
0.7 |
|
| 2019 |
Hassel S, Sharma GB, Alders GL, Davis AD, Arnott SR, Frey BN, Hall GB, Harris JK, Lam RW, Milev R, Müller DJ, Rotzinger S, Zamyadi M, Kennedy SH, Strother SC, et al. Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants. Human Brain Mapping. PMID 31794150 DOI: 10.1002/Hbm.24883 |
0.641 |
|
| 2019 |
Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, et al. Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study. Journal of Affective Disorders. PMID 31757619 DOI: 10.1016/J.Jad.2019.11.068 |
0.735 |
|
| 2019 |
Fonseka TM, Pong JT, Kcomt A, Kennedy SH, Parikh SV. Collaborating with individuals with lived experience to adapt CANMAT clinical depression guidelines into a patient treatment guide: The CHOICE-D co-design process. Journal of Evaluation in Clinical Practice. PMID 31729117 DOI: 10.1111/Jep.13308 |
0.379 |
|
| 2019 |
Stowkowy J, Brummitt K, Bonneville D, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, MacQueen G, Addington J. Sleep disturbances in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 31724327 DOI: 10.1111/Eip.12898 |
0.582 |
|
| 2019 |
Dunlop K, Sheen J, Schulze L, Fettes P, Mansouri F, Feffer K, Blumberger DM, Daskalakis ZJ, Kennedy SH, Giacobbe P, Woodside B, Downar J. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial. Brain Stimulation. PMID 31711880 DOI: 10.1016/J.Brs.2019.10.020 |
0.386 |
|
| 2019 |
Caspani G, Kennedy S, Foster JA, Swann J. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial Cell (Graz, Austria). 6: 454-481. PMID 31646148 DOI: 10.15698/Mic2019.10.693 |
0.409 |
|
| 2019 |
Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, ... ... Kennedy SH, et al. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31610545 DOI: 10.1038/S41386-019-0542-1 |
0.828 |
|
| 2019 |
Vaccarino SR, McInerney SJ, Kennedy SH, Bhat V. The Potential Procognitive Effects of Modafinil in Major Depressive Disorder: A Systematic Review. The Journal of Clinical Psychiatry. 80. PMID 31599501 DOI: 10.4088/Jcp.19R12767 |
0.74 |
|
| 2019 |
Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, ... ... Kennedy SH, et al. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9: 254. PMID 31594917 DOI: 10.1038/S41398-019-0589-0 |
0.672 |
|
| 2019 |
Chakrabarty T, Harkness KL, McInerney SJ, Quilty LC, Milev RV, Kennedy SH, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Uher R, Lam RW. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 1-12. PMID 31583989 DOI: 10.1017/S003329171900268X |
0.681 |
|
| 2019 |
Sankar T, Chakravarty MM, Jawa N, Li SX, Giacobbe P, Kennedy SH, Rizvi SJ, Mayberg HS, Hamani C, Lozano AM. Neuroanatomical predictors of response to subcallosal cingulate deep brain stimulation for treatment-resistant depression Journal of Psychiatry & Neuroscience : Jpn. 44: 1-10. PMID 31525860 DOI: 10.1503/Jpn.180207 |
0.407 |
|
| 2019 |
Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 31502422 DOI: 10.1111/Eip.12872 |
0.6 |
|
| 2019 |
Davis AD, Hassel S, Arnott SR, Harris J, Lam RW, Milev R, Rotzinger S, Zamyadi M, Frey BN, Minuzzi L, Strother SC, MacQueen GM, Kennedy SH, Hall GB. White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471185 DOI: 10.1016/J.Bpsc.2019.05.016 |
0.684 |
|
| 2019 |
Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, et al. Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study. Journal of Affective Disorders. 257: 765-773. PMID 31400735 DOI: 10.1016/J.Jad.2019.07.037 |
0.638 |
|
| 2019 |
Fonseka TM, Bhat V, Kennedy SH. The utility of artificial intelligence in suicide risk prediction and the management of suicidal behaviors. The Australian and New Zealand Journal of Psychiatry. 4867419864428. PMID 31347389 DOI: 10.1177/0004867419864428 |
0.63 |
|
| 2019 |
Brietzke E, Hawken ER, Idzikowski M, Pong J, Kennedy SH, Soares CN. Integrating digital phenotyping in clinical characterization of individuals with mood disorders. Neuroscience and Biobehavioral Reviews. PMID 31330197 DOI: 10.1016/J.Neubiorev.2019.07.009 |
0.417 |
|
| 2019 |
Braun Janzen T, Al Shirawi MI, Rotzinger S, Kennedy SH, Bartel L. A Pilot Study Investigating the Effect of Music-Based Intervention on Depression and Anhedonia. Frontiers in Psychology. 10: 1038. PMID 31133945 DOI: 10.3389/Fpsyg.2019.01038 |
0.475 |
|
| 2019 |
Espinet S, Corrin T, Baliunas D, Quilty L, Zawertailo L, Rizvi SJ, deRuiter W, Bonato S, De Luca V, Kennedy S, Selby P. Predisposing and protective factors influencing suicide ideation, attempt, and death in patients accessing substance use treatment: a systematic review and meta-analysis protocol. Systematic Reviews. 8: 115. PMID 31092292 DOI: 10.1186/S13643-019-1028-2 |
0.326 |
|
| 2019 |
Belzeaux R, Fiori LM, Lopez JP, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, ... ... Kennedy SH, et al. Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. The Journal of Clinical Psychiatry. 80. PMID 31087825 DOI: 10.4088/Jcp.18M12556 |
0.643 |
|
| 2019 |
Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Bray SL, Lebel C, Addington JM, ... ... Kennedy SH, et al. Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage. PMID 31075395 DOI: 10.1016/J.Neuroimage.2019.05.017 |
0.777 |
|
| 2019 |
Boschloo L, Bekhuis E, Weitz ES, Reijnders M, DeRubeis RJ, Dimidjian S, Dunner DL, Dunlop BW, Hegerl U, Hollon SD, Jarrett RB, Kennedy SH, Miranda J, Mohr DC, Simons AD, et al. The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 183-191. PMID 31059603 DOI: 10.1002/Wps.20630 |
0.472 |
|
| 2019 |
Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, et al. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 80. PMID 30840787 DOI: 10.4088/Jcp.18M12202 |
0.727 |
|
| 2019 |
MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, ... ... Kennedy SH, et al. The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols Journal of Psychiatry & Neuroscience : Jpn. 44: 1-14. PMID 30840428 DOI: 10.1503/Jpn.180036 |
0.688 |
|
| 2019 |
Kaster TS, Downar J, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Blumberger DM. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. The American Journal of Psychiatry. appiajp201818091096. PMID 30764649 DOI: 10.1176/Appi.Ajp.2018.18091096 |
0.473 |
|
| 2019 |
Slyepchenko A, Allega OR, Leng X, Minuzzi L, Eltayebani MM, Skelly M, Sassi RB, Soares CN, Kennedy SH, Frey BN. Association of functioning and quality of life with objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder. The Australian and New Zealand Journal of Psychiatry. 4867419829228. PMID 30759998 DOI: 10.1177/0004867419829228 |
0.525 |
|
| 2019 |
Dhanju S, Kennedy SH, Abbey S, Katz J, Weinrib A, Clarke H, Bhat V, Ladha K. The impact of comorbid pain and depression in the United States: results from a nationally representative survey. Scandinavian Journal of Pain. PMID 30759071 DOI: 10.1515/Sjpain-2018-0323 |
0.69 |
|
| 2019 |
Addington J, Liu L, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Stowkowy J, MacQueen G. Clinical staging for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 30672153 DOI: 10.1111/Eip.12786 |
0.604 |
|
| 2019 |
Bhat V, Leng X, Lam R, Milev R, Foster J, Lou W, Kennedy SH. Distinct Network Structure of Depression Symptoms Among Responders and Non-Responders To Antidepressants and Placebo Journal of Affective Disorders. 254: 147. DOI: 10.1016/J.Jad.2018.10.329 |
0.419 |
|
| 2019 |
Islam F, Marshe V, Maciukiewicz M, Lam R, MacQueen G, Frey B, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster JA, Kennedy S, Mueller D. M31 Impact Of Cyp2C19 And Cyp2D6 Gene Variants On Plasma Levels And Treatment Response In Patients Receiving Escitalopram And Aripiprazole For Major Depression: Results From The Can-Bind-1 Cohort European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.131 |
0.675 |
|
| 2019 |
Kennedy SH, Heun R, Avedisova AS, Ahokas A, Olivier V, Picarel-Blanchot F, Bodinat CD. Functional outcome in patients with major depressive disorder treated by agomelatine 25-50 mg as compared to placebo European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.376 |
0.452 |
|
| 2019 |
Maciukiewicz M, Marshe V, Hauschild A, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE AND REMISSION IN MAJOR DEPRESSIVE DISORDER European Neuropsychopharmacology. 29: S843. DOI: 10.1016/J.Euroneuro.2017.08.110 |
0.414 |
|
| 2019 |
Ng E, Lipsman N, Hamani C, Lozano A, Kennedy S, Giacobbe P. Adverse Childhood Experiences and Deep Brain Stimulation Outcomes for Treatment Resistant Depression Brain Stimulation. 12: 548. DOI: 10.1016/J.Brs.2018.12.811 |
0.401 |
|
| 2019 |
Islam F, Marshe V, Maciukiewicz M, Yoshida K, Lam RW, MacQueen G, Frey BN, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster J, Kennedy SH, et al. S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.875 |
0.681 |
|
| 2019 |
Nogovitsyn N, Srajer A, Muller M, Metzak P, Hassel S, Souza R, Bray S, Lebel C, Goldstein B, Kennedy S, Ismail Z, Protzner A, Addington J, MacQueen G. F130. Subfield-Specific Hippocampal Volumes in Youth at Risk for Mental Illness Biological Psychiatry. 85: S263-S264. DOI: 10.1016/J.Biopsych.2019.03.667 |
0.768 |
|
| 2019 |
Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Bray S, Lebel C, Addington J, Milev R, Harkness K, ... ... Kennedy SH, et al. F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.650 |
0.822 |
|
| 2019 |
Suh JS, Minuzzi L, Raamana P, Strother SC, MacQueen GM, Hassel S, Alders G, Arnott S, Davis AD, Harris JK, Sharma GB, Zamyadi M, Blier P, Downar J, Farzan F, ... ... Kennedy SH, et al. F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder Biological Psychiatry. 85: S254. DOI: 10.1016/J.Biopsych.2019.03.644 |
0.614 |
|
| 2019 |
Slyepchenko A, Allega O, Leng X, Minuzzi L, Eltayebani MM, Skelly M, Sassi R, Soares C, Kennedy S, Frey BN. T97. Predicting Functioning and Quality of Life Using Objective and Subjective Measures of Sleep and Biological Rhythms in Major Depressive and Bipolar Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.420 |
0.573 |
|
| 2018 |
Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Focus (American Psychiatric Publishing). 16: 85-94. PMID 32015703 DOI: 10.1176/appi.focus.16106 |
0.575 |
|
| 2018 |
Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Neurocognitive deficits in a transdiagnostic clinical staging model. Psychiatry Research. PMID 30360915 DOI: 10.1016/J.Psychres.2018.10.030 |
0.622 |
|
| 2018 |
Allen TA, Lam RW, Milev R, Rizvi SJ, Frey BN, MacQueen GM, Müller DJ, Uher R, Kennedy SH, Quilty LC. Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 1-10. PMID 30220263 DOI: 10.1017/S0033291718002441 |
0.733 |
|
| 2018 |
Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Family functioning in youth at-risk for serious mental illness. Comprehensive Psychiatry. 87: 17-24. PMID 30193153 DOI: 10.1016/J.Comppsych.2018.08.010 |
0.612 |
|
| 2018 |
Suh JS, Schneider MA, Minuzzi L, MacQueen GM, Strother SC, Kennedy SH, Frey BN. Cortical thickness in major depressive disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30118825 DOI: 10.1016/J.Pnpbp.2018.08.008 |
0.69 |
|
| 2018 |
Farris MS, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Treatment History of Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718792195. PMID 30071747 DOI: 10.1177/0706743718792195 |
0.625 |
|
| 2018 |
Addington J, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, Hassel S, Marshall C, MacQueen G. Youth at-risk for serious mental illness: methods of the PROCAN study. Bmc Psychiatry. 18: 219. PMID 29976184 DOI: 10.1186/S12888-018-1801-0 |
0.611 |
|
| 2018 |
Bhat V, Kennedy SH. Vagus Nerve Stimulation: A Treatment in Evolution. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 31: 99-100. PMID 29927801 DOI: 10.1097/Wnn.0000000000000155 |
0.605 |
|
| 2018 |
Kennedy SH, Heun R, Avedisova A, Ahokas A, Olivier V, Picarel-Blanchot F, de Bodinat C. Effect of agomelatine 25-50 mg on functional outcomes in patients with major depressive disorder. Journal of Affective Disorders. 238: 122-128. PMID 29879606 DOI: 10.1016/J.Jad.2018.05.060 |
0.486 |
|
| 2018 |
Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet (London, England). 391: 1683-1692. PMID 29726344 DOI: 10.1016/S0140-6736(18)30295-2 |
0.437 |
|
| 2018 |
Lambert C, Da Silva S, Ceniti AK, Rizvi SJ, Foussias G, Kennedy SH. Anhedonia in depression and schizophrenia: A transdiagnostic challenge. Cns Neuroscience & Therapeutics. PMID 29687627 DOI: 10.1111/Cns.12854 |
0.416 |
|
| 2018 |
Fettes PW, Moayedi M, Dunlop K, Mansouri F, Vila-Rodriguez F, Giacobbe P, Davis KD, Lam RW, Kennedy SH, Daskalakis ZJ, Blumberger DM, Downar J. Abnormal Functional Connectivity of Frontopolar Subregions in Treatment-Nonresponsive Major Depressive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 337-347. PMID 29628066 DOI: 10.1016/J.Bpsc.2017.12.003 |
0.489 |
|
| 2018 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. PMID 29536616 DOI: 10.1111/Bdi.12609 |
0.705 |
|
| 2018 |
Rizvi SJ, Lambert C, Kennedy S. Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions. Current Psychiatry Reports. 20: 13. PMID 29520717 DOI: 10.1007/S11920-018-0877-Z |
0.376 |
|
| 2018 |
Giacobbe P, Rakita U, Penner-Goeke K, Feffer K, Flint AJ, Kennedy SH, Downar J. Improvements in Health-Related Quality of Life With Electroconvulsive Therapy: A Meta-Analysis. The Journal of Ect. PMID 29461332 DOI: 10.1097/Yct.0000000000000486 |
0.351 |
|
| 2018 |
Maciukiewicz M, Marshe VS, Hauschild AC, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. Journal of Psychiatric Research. 99: 62-68. PMID 29407288 DOI: 10.1016/J.Jpsychires.2017.12.009 |
0.394 |
|
| 2018 |
Ghanean H, Ceniti AK, Kennedy SH. Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management. Cns Drugs. PMID 29383573 DOI: 10.1007/S40263-018-0490-Z |
0.494 |
|
| 2018 |
Kennedy SH, Grouin JM, Cadour S, Robert V, Picarel-Blanchot F. Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder. Human Psychopharmacology. PMID 29327372 DOI: 10.1002/Hup.2646 |
0.481 |
|
| 2018 |
Kennedy SH, Wittchen HU. Editorial: mood and anxiety disorders. Current Opinion in Psychiatry. 31: 1-2. PMID 29176393 DOI: 10.1097/Yco.0000000000000386 |
0.38 |
|
| 2018 |
Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. S80. NEUROCOGNITIVE FUNCTIONING IN YOUTH AT RISK OF SERIOUS MENTAL ILLNESS Schizophrenia Bulletin. 44: S355-S356. DOI: 10.1093/Schbul/Sby018.867 |
0.594 |
|
| 2018 |
Blumberger D, Vila-Rodriguez F, Thorpe K, Feffer K, Nodaa Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J. 222. Clinical Results From the Theta Burst Versus High Frequency Repetitive Transcranial Magnetic Stimulation Effectiveness Evaluation in Depression (THREE-D) Randomized Non-Inferiority Trial Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.241 |
0.353 |
|
| 2018 |
McInerney S, Frey BN, Milev R, Chakrabarty T, Woo C, Kennedy SH, Lam RW. S120. Canadian Biomarker Integration Network in Depression (CAN-BIND): Baseline and Follow up Neurocognitive Mediators of Functioning in Major Depressive Disorder (MDD) Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1011 |
0.649 |
|
| 2017 |
Kennedy SH, Ceniti AK. Unpacking Major Depressive Disorder: From Classification to Treatment Selection. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717748883. PMID 29278937 DOI: 10.1177/0706743717748883 |
0.495 |
|
| 2017 |
Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, Pat McAndrews M, Blier P, Evans K, Foster JA, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Müller DJ, ... ... Kennedy SH, et al. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227: 542-549. PMID 29169123 DOI: 10.1016/J.Jad.2017.10.028 |
0.664 |
|
| 2017 |
Fonseka TM, MacQueen GM, Kennedy SH. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. Journal of Affective Disorders. PMID 29150145 DOI: 10.1016/J.Jad.2017.10.049 |
0.645 |
|
| 2017 |
Feffer K, Lee HH, Mansouri F, Giacobbe P, Vila-Rodriguez F, Kennedy SH, Daskalakis ZJ, Blumberger DM, Downar J. Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression. Brain Stimulation. PMID 29107623 DOI: 10.1016/J.Brs.2017.10.010 |
0.341 |
|
| 2017 |
Giacobbe P, Rakita U, Lam R, Milev R, Kennedy SH, McIntyre RS. Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials. Journal of Affective Disorders. 226: 294-300. PMID 29028590 DOI: 10.1016/J.Jad.2017.09.041 |
0.406 |
|
| 2017 |
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-19. PMID 28984491 DOI: 10.1080/15622975.2017.1379609 |
0.481 |
|
| 2017 |
Allega OR, Leng X, Vaccarino A, Skelly M, Lanzini M, Paz Hidalgo M, Soares CN, Kennedy SH, Frey BN. Performance of the biological rhythms interview for assessment in neuropsychiatry: An item response theory and actigraphy analysis. Journal of Affective Disorders. 225: 54-63. PMID 28787704 DOI: 10.1016/J.Jad.2017.07.047 |
0.496 |
|
| 2017 |
Farzan F, Atluri S, Frehlich M, Dhami P, Kleffner K, Price R, Lam RW, Frey BN, Milev R, Ravindran A, McAndrews MP, Wong W, Blumberger D, Daskalakis ZJ, Vila-Rodriguez F, ... ... Kennedy SH, et al. Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific Reports. 7: 7473. PMID 28785082 DOI: 10.1038/S41598-017-07613-X |
0.539 |
|
| 2017 |
Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, Rotzinger S, Foster JA, Kennedy SH, Müller DJ. Genome-wide association studies of placebo and duloxetine response in major depressive disorder. The Pharmacogenomics Journal. PMID 28696415 DOI: 10.1038/Tpj.2017.29 |
0.401 |
|
| 2017 |
Bhat V, Kennedy SH. Recognition and management of antidepressant discontinuation syndrome. Journal of Psychiatry & Neuroscience : Jpn. 42: E7-E8. PMID 28639936 DOI: 10.1503/Jpn.170022 |
0.616 |
|
| 2017 |
Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Bipolar Disorders. 19: 198-213. PMID 28599348 DOI: 10.1111/Bdi.12496 |
0.47 |
|
| 2017 |
McIntyre RS, Lee Y, Zhou AJ, Rosenblat JD, Peters EM, Lam RW, Kennedy SH, Rong C, Jerrell JM. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. Journal of Clinical Psychopharmacology. PMID 28590365 DOI: 10.1097/Jcp.0000000000000723 |
0.483 |
|
| 2017 |
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, ... ... Kennedy SH, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8: 15497. PMID 28530238 DOI: 10.1038/Ncomms15497 |
0.647 |
|
| 2017 |
Lam RW, Ismail Z, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, Kennedy SH. Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 62: 353-354. PMID 28525728 DOI: 10.1177/0706743717700878 |
0.616 |
|
| 2017 |
Fiori LM, Lopez JP, Richard-Devantoy S, Berlim M, Chachamovich E, Jollant F, Foster J, Rotzinger S, Kennedy S, Turecki G. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response. The International Journal of Neuropsychopharmacology. PMID 28520926 DOI: 10.1093/Ijnp/Pyx034 |
0.395 |
|
| 2017 |
Al Shirawi MI, Kennedy SH, Ho KT, Byrne R, Downar J. Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series. Journal of Clinical Psychopharmacology. PMID 28514237 DOI: 10.1097/Jcp.0000000000000717 |
0.427 |
|
| 2017 |
McInerney SJ, McNeely HE, Geraci J, Giacobbe P, Rizvi SJ, Ceniti AK, Cyriac A, Mayberg HS, Lozano AM, Kennedy SH. Neurocognitive Predictors of Response in Treatment Resistant Depression to Subcallosal Cingulate Gyrus Deep Brain Stimulation. Frontiers in Human Neuroscience. 11: 74. PMID 28286473 DOI: 10.3389/Fnhum.2017.00074 |
0.422 |
|
| 2017 |
Parikh SV, Quilty L, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Uher R, Kennedy SH, Lam RW, MacQueen GM, Milev R, Ravindran AV. Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 62: 77-78. PMID 28055254 DOI: 10.1177/0706743716676754 |
0.613 |
|
| 2017 |
Al Shirawi MI, Edgar NE, Kennedy SH. Brexpiprazole in the Treatment of Major Depressive Disorder Clinical Medicine Insights: Therapeutics. 9: 1179559X1773180. DOI: 10.1177/1179559X17731801 |
0.422 |
|
| 2017 |
Harkness KL, Foster J, Li M, MacQueen G, Milev R, Frey B, Kennedy S. Childhood maltreatment and markers of neuroinflammation predict response to anti-depressant treatment in adults with major depressive disorder Psychoneuroendocrinology. 83: 73. DOI: 10.1016/J.Psyneuen.2017.07.435 |
0.732 |
|
| 2017 |
Blumberger DM, Vila-Rodriguez F, Daskalakis ZJ, Giacobbe P, Lam RW, Kennedy SH, Downar J. Design of the theta burst versus high frequency rTMS effectiveness evaluation in depression (THREE-D) non-inferiority trial Brain Stimulation. 10: 424. DOI: 10.1016/J.Brs.2017.01.258 |
0.361 |
|
| 2017 |
Hassel S, Davis A, Hall G, Foster J, Harkness K, Harris J, Zamyadi M, Arnott S, Alders G, Rotzinger S, Strother S, Kennedy S, MacQueen G. 754. Inflammatory Markers as Mediators of the Association between Early Life Adversity and Hippocampal Volume in Adult Patients with depression: Findings from Phase 1 of the CAN-BIND Study Biological Psychiatry. 81: S306. DOI: 10.1016/J.Biopsych.2017.02.821 |
0.568 |
|
| 2017 |
Harkness K, Wynne-Edwards K, Foster J, Rotzinger S, Kennedy S. 751. The Role of Childhood Maltreatment in Depression: Overview of the Literature and Insights from the CAN-BIND Program Biological Psychiatry. 81: S304-S305. DOI: 10.1016/J.Biopsych.2017.02.818 |
0.388 |
|
| 2017 |
Dunlop K, Peters SK, Giacobbe P, Daskalakis Z, Lam RW, Kennedy S, Vila-Rodriguez F, Blumberger DM, Downar J. 608. Baseline Resting-State fMRI Biomarkers of Depression Response to DLPFC-rTMS: Different Patterns of Functional Connectivity Predict Response to 10 Hz rTMS and Intermittant TBS Biological Psychiatry. 81: S246. DOI: 10.1016/J.Biopsych.2017.02.478 |
0.379 |
|
| 2016 |
Cha DS, Best MW, Bowie CR, Gallaugher LA, Woldeyohannes HO, Soczynska JK, Lewis G, MacQueen G, Sahakian BJ, Kennedy SH, Lui JP, Mansur RB, McIntyre RS. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder. Journal of Affective Disorders. 210: 57-65. PMID 28013123 DOI: 10.1016/J.Jad.2016.12.006 |
0.599 |
|
| 2016 |
Vaccarino AL, Evans KR, Kalali AH, Kennedy SH, Engelhardt N, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Placenza FM, Ravindran AV, Sheehan DV, Sills T, et al. The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder. Innovations in Clinical Neuroscience. 13: 20-31. PMID 27974997 |
0.699 |
|
| 2016 |
Mak LE, Minuzzi L, MacQueen G, Hall G, Kennedy S, Milev R. The Default Mode Network in Healthy Individuals: A Systematic Review and Meta-Analysis. Brain Connectivity. PMID 27917679 DOI: 10.1089/Brain.2016.0438 |
0.511 |
|
| 2016 |
Zhou AJ, Lee Y, Salvadore G, Hsu B, Fonseka TM, Kennedy SH, McIntyre RS. Sirukumab: A Potential Treatment for Mood Disorders? Advances in Therapy. PMID 27913990 DOI: 10.1007/S12325-016-0455-X |
0.411 |
|
| 2016 |
Schulze L, Remington G, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. Journal of Psychopharmacology (Oxford, England). PMID 27852961 DOI: 10.1177/0269881116675516 |
0.426 |
|
| 2016 |
Habert J, Katzman MA, Oluboka OJ, McIntyre RS, McIntosh D, MacQueen GM, Khullar A, Milev RV, Kjernisted KD, Chokka PR, Kennedy SH. Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment. The Primary Care Companion For Cns Disorders. 18. PMID 27835721 DOI: 10.4088/Pcc.15R01926 |
0.639 |
|
| 2016 |
Malhi GS, Byrow Y, Cassidy F, Cipriani A, Demyttenaere K, Frye MA, Gitlin M, Kennedy SH, Ketter TA, Lam RW, McShane R, Mitchell AJ, Ostacher MJ, Rizvi SJ, Thase ME, et al. Ketamine: stimulating antidepressant treatment? Bjpsych Open. 2: e5-e9. PMID 27703782 DOI: 10.1192/Bjpo.Bp.116.002923 |
0.489 |
|
| 2016 |
Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, MacQueen GM, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486154 DOI: 10.1177/0706743716660033 |
0.595 |
|
| 2016 |
Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486153 DOI: 10.1177/0706743716660290 |
0.641 |
|
| 2016 |
Lam RW, Kennedy SH, Parikh SV, MacQueen GM, Milev RV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486152 DOI: 10.1177/0706743716659061 |
0.635 |
|
| 2016 |
Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song WY, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486151 DOI: 10.1177/0706743716659416 |
0.636 |
|
| 2016 |
Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486150 DOI: 10.1177/0706743716659418 |
0.641 |
|
| 2016 |
MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Van Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486149 DOI: 10.1177/0706743716659276 |
0.72 |
|
| 2016 |
Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486148 DOI: 10.1177/0706743716659417 |
0.782 |
|
| 2016 |
McIntyre RS, Woldeyohannes HO, Soczynska JK, Vinberg M, Cha DS, Lee Y, Gallaugher LA, Dale RS, Alsuwaidan MT, Mansur RB, Muzina DJ, Carvalho A, Kennedy S. The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project. Therapeutic Advances in Chronic Disease. 7: 153-9. PMID 27347362 DOI: 10.1177/2040622315627805 |
0.453 |
|
| 2016 |
Nowrouzi B, McIntyre RS, MacQueen G, Kennedy SH, Kennedy JL, Ravindran A, Yatham L, De Luca V. Admixture analysis of age at onset in first episode bipolar disorder. Journal of Affective Disorders. 201: 88-94. PMID 27182964 DOI: 10.1016/J.Jad.2016.04.006 |
0.552 |
|
| 2016 |
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Geraci J, Giacobbe P, ... ... Kennedy SH, et al. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. Bmc Psychiatry. 16: 105. PMID 27084692 DOI: 10.1186/S12888-016-0785-X |
0.716 |
|
| 2016 |
Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: Potentials and pitfalls. Neuroscience and Biobehavioral Reviews. PMID 26959336 DOI: 10.1016/J.Neubiorev.2016.03.004 |
0.399 |
|
| 2016 |
Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, et al. Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. The American Journal of Psychiatry. appiajp201515040492. PMID 26869246 DOI: 10.1176/Appi.Ajp.2015.15040492 |
0.366 |
|
| 2016 |
Fonseka TM, Wen XY, Foster JA, Kennedy SH. Zebrafish models of major depressive disorders. Journal of Neuroscience Research. 94: 3-14. PMID 26452974 DOI: 10.1002/Jnr.23639 |
0.423 |
|
| 2016 |
Rizvi S, Strafella A, Rusjan P, Sproule B, Kennedy S. The prominence of anhedonia in treatment-resistant depression and links to dopamine receptor binding European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31330-X |
0.369 |
|
| 2015 |
McIntyre RS, Woldeyohannes HO, Soczynska JK, Maruschak NA, Wium-Andersen IK, Vinberg M, Cha DS, Lee Y, Xiao HX, Gallaugher LA, Dale RM, Alsuwaidan MT, Mansur RB, Muzina DJ, Carvalho AF, ... ... Kennedy SH, et al. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project. Cns Spectrums. 1-5. PMID 26714651 DOI: 10.1017/S1092852915000747 |
0.44 |
|
| 2015 |
Kennedy SH, Avedisova A, Belaïdi C, Picarel-Blanchot F, de Bodinat C. Sustained efficacy of agomelatine 10mg, 25mg, and 25-50mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26708320 DOI: 10.1016/J.Euroneuro.2015.09.006 |
0.354 |
|
| 2015 |
Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Rotzinger S, Foster JA, Kennedy JL, Kennedy SH, Müller DJ. Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder. Pharmacogenomics. PMID 26556688 DOI: 10.2217/Pgs.15.136 |
0.374 |
|
| 2015 |
Woldeyohannes HO, Soczynska JK, Maruschak NA, Syeda K, Wium-Andersen IK, Lee Y, Cha DS, Xiao HX, Gallaugher LA, Dale RM, Alsuwaidan MT, Mansur RB, Muzina DJ, Carvalho AF, Jerrell J, ... Kennedy S, et al. Binge eating in adults with mood disorders: Results from the International Mood Disorders Collaborative Project. Obesity Research & Clinical Practice. PMID 26508286 DOI: 10.1016/J.Orcp.2015.10.002 |
0.39 |
|
| 2015 |
Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Cristea IA, Faramarzi M, Hegerl U, Jarrett RB, Kheirkhah F, Kennedy SH, et al. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. Jama Psychiatry. PMID 26397232 DOI: 10.1001/Jamapsychiatry.2015.1516 |
0.462 |
|
| 2015 |
Rizvi SJ, Sproule BA, Gallaugher L, McIntyre RS, Kennedy SH. Correlates of benzodiazepine use in major depressive disorder: The effect of anhedonia. Journal of Affective Disorders. 187: 101-5. PMID 26331683 DOI: 10.1016/J.Jad.2015.07.040 |
0.462 |
|
| 2015 |
Dunlop K, Gaprielian P, Blumberger D, Daskalakis ZJ, Kennedy SH, Giacobbe P, Downar J. MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder. Journal of Visualized Experiments : Jove. e53129. PMID 26327307 DOI: 10.3791/53129 |
0.445 |
|
| 2015 |
Rizvi SJ, Quilty LC, Sproule BA, Cyriac A, Michael Bagby R, Kennedy SH. Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression. Psychiatry Research. 229: 109-19. PMID 26250147 DOI: 10.1016/J.Psychres.2015.07.062 |
0.382 |
|
| 2015 |
Sun Y, Giacobbe P, Tang CW, Barr MS, Rajji T, Kennedy SH, Fitzgerald PB, Lozano AM, Wong W, Daskalakis ZJ. Deep Brain Stimulation Modulates Gamma Oscillations and Theta-Gamma Coupling in Treatment Resistant Depression. Brain Stimulation. PMID 26195320 DOI: 10.1016/J.Brs.2015.06.010 |
0.397 |
|
| 2015 |
Fonseka TM, McIntyre RS, Soczynska JK, Kennedy SH. Evidence to support peripheral and central IL-6 signaling targets to treat depression. Expert Opinion On Investigational Drugs. 24: 991-2. PMID 26082086 DOI: 10.1517/13543784.2015.1057675 |
0.347 |
|
| 2015 |
Lam RW, Parikh SV, Michalak EE, Dewa CS, Kennedy SH. Canadian Network for Mood and Anxiety Treatments (CANMAT) consensus recommendations for functional outcomes in major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 142-9. PMID 25954941 |
0.382 |
|
| 2015 |
Rizvi SJ, Cyriac A, Grima E, Tan M, Lin P, Gallaugher LA, Mcintyre RS, Kennedy SH. Depression and employment status in primary and tertiary care settings. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 14-22. PMID 25886545 DOI: 10.1177/070674371506000105 |
0.439 |
|
| 2015 |
Lam RW, Kennedy SH. STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby! Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 6-8. PMID 25886543 DOI: 10.1177/070674371506000103 |
0.426 |
|
| 2015 |
Fonseka TM, McIntyre RS, Soczynska JK, Kennedy SH. Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opinion On Investigational Drugs. 24: 459-75. PMID 25585966 DOI: 10.1517/13543784.2014.998334 |
0.302 |
|
| 2015 |
Srejic LR, Prescott IA, Zhang P, Strauss I, Dostrovsky JO, Giacobbe P, Kennedy SH, Lozano AM, Hamani C, Hutchison WD. Paired Pulse Depression in the Subcallosal Cingulate Region of Depression Patients. Biological Psychiatry. 78: e3-4. PMID 25582268 DOI: 10.1016/J.Biopsych.2014.09.018 |
0.435 |
|
| 2015 |
Bakker N, Shahab S, Giacobbe P, Blumberger DM, Daskalakis ZJ, Kennedy SH, Downar J. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimulation. 8: 208-15. PMID 25465290 DOI: 10.1016/J.Brs.2014.11.002 |
0.379 |
|
| 2015 |
McIntyre RS, Soczynska JZ, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Carvalho AF, Jerrell JM, Dale RM, Gallaugher LA, Muzina DJ, Kennedy SH. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Comprehensive Psychiatry. 56: 279-82. PMID 25439523 DOI: 10.1016/J.Comppsych.2014.08.051 |
0.445 |
|
| 2015 |
Downar J, Dunlop K, Schultze LL, Mansouri F, Vila-Rodriguez F, Giacobbe P, Kennedy SH, Daskalakis ZJ, Blumberger DM. Resting-state functional connectivity to subgenual cingulate cortex differentially predicts treatment response for 10 Hz versus intermittent theta-burst rTMS in major depression Brain Stimulation. 8: 396. DOI: 10.1016/J.Brs.2015.01.265 |
0.313 |
|
| 2015 |
Bakker N, Shahab S, Giacobbe P, Blumberger DM, Daskalakis ZJ, Kennedy SH, Downar J. Dorsomedial prefrontal rTMS for major depression: safety, tolerability, and effectiveness for 10 Hz versus iTBS 185 in consecutive cases Brain Stimulation. 8: 325. DOI: 10.1016/J.Brs.2015.01.053 |
0.399 |
|
| 2014 |
Lam RW, Kennedy SH, Mclntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 649-54. PMID 25702365 DOI: 10.1177/070674371405901206 |
0.399 |
|
| 2014 |
McInerney SJ, Kennedy SH. Review of evidence for use of antidepressants in bipolar depression. The Primary Care Companion For Cns Disorders. 16. PMID 25667812 DOI: 10.4088/Pcc.14R01653 |
0.503 |
|
| 2014 |
McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project. Journal of Affective Disorders. 172: 259-264. PMID 25451425 DOI: 10.1016/J.Jad.2014.09.026 |
0.44 |
|
| 2014 |
Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Jarrett RB, Kennedy SH, Kheirkhah F, Mergl R, et al. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis. Depression and Anxiety. 31: 941-51. PMID 25407584 DOI: 10.1002/Da.22328 |
0.419 |
|
| 2014 |
Rizvi SJ, Geraci J, Ravindran A, Kennedy SH. Predictors of response to adjunctive osmotic-release methylphenidate or placebo in patients with major depressive disorder: effects of apathy/anhedonia and fatigue. Journal of Clinical Psychopharmacology. 34: 755-9. PMID 25203470 DOI: 10.1097/Jcp.0000000000000211 |
0.467 |
|
| 2014 |
Soczynska JK, Ravindran LN, Styra R, McIntyre RS, Cyriac A, Manierka MS, Kennedy SH. The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial. Psychiatry Research. 220: 245-50. PMID 25124683 DOI: 10.1016/J.Psychres.2014.06.053 |
0.331 |
|
| 2014 |
Kennedy SH, Giacobbe P, Placenza F, Hudson CJ, Seeman P, Seeman MV. Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study Journal of Affective Disorders. 166: 139-143. PMID 25012422 DOI: 10.1016/J.Jad.2014.04.014 |
0.388 |
|
| 2014 |
Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, Mcintyre RS, Kennedy SH. Treatment-resistant depression in primary care across Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 349-57. PMID 25007419 DOI: 10.1177/070674371405900702 |
0.433 |
|
| 2014 |
Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, Bakker N, Blumberger DM, Daskalakis ZJ, Kennedy SH, Flint AJ, Giacobbe P. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biological Psychiatry. 76: 176-85. PMID 24388670 DOI: 10.1016/J.Biopsych.2013.10.026 |
0.467 |
|
| 2014 |
Quraan MA, Protzner AB, Daskalakis ZJ, Giacobbe P, Tang CW, Kennedy SH, Lozano AM, McAndrews MP. EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1270-81. PMID 24285211 DOI: 10.1038/Npp.2013.330 |
0.355 |
|
| 2014 |
Salomons TV, Dunlop K, Kennedy SH, Flint A, Geraci J, Giacobbe P, Downar J. Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 488-98. PMID 24150516 DOI: 10.1038/Npp.2013.222 |
0.442 |
|
| 2014 |
Lipsman N, Sankar T, Downar J, Kennedy SH, Lozano AM, Giacobbe P. Neuromodulation for treatment-refractory major depressive disorder. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 186: 33-9. PMID 23897945 DOI: 10.1503/Cmaj.121317 |
0.494 |
|
| 2014 |
Soczynksa J, Kennedy SH, Alsuwaidan M, Mansur R, Li M, McAndrews MP, Brietzke E, Taylor V, McIntyre RS. P.2.d.054 A pilot, open-label, 8-week study evaluating the efficacy of adjunctive minocycline for the treatment of bipolar I/II depression European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70712-6 |
0.408 |
|
| 2014 |
Kennedy S, Avedisova A, Picarel-Blanchot F, Bodinat CD. P.2.b.045 Efficacy of 3 agomelatine dose regimens versus placebo on the core symptoms of depression and functioning European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70646-7 |
0.374 |
|
| 2014 |
Kennedy SH, Avedisova A, Picarel F, Bodinat CD. EPA-0396 – Sustained efficacy and safety of agomelatine 10, 25 and 25–50mg versus placebo over 24 weeks in out-patients suffering from moderate to severe major depressive disorder European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77819-8 |
0.342 |
|
| 2014 |
Kennedy SH, Avedisova A, Giménez-Montesinos N, Belaïdi C, Christian de B, Corral RM, Caches MA, Lamaison HF, Gargoloff PR, Lupo C, Finkelsztein C, Berardo GM, Mosca D, Serfaty EM, Kuper E, et al. A placebo-controlled study of three agomelatine dose regimens (10mg, 25mg, 25-50mg) in patients with major depressive disorder European Neuropsychopharmacology. 24: 553-563. DOI: 10.1016/J.Euroneuro.2014.01.006 |
0.324 |
|
| 2013 |
Kennedy SH. Comments on the Use of Agomelatine in the Treatment of Depressive Disorder According to Clinical Guidelines in Colombia Revista Colombiana De PsiquiatríA. 42: 356-357. PMID 26573120 DOI: 10.1016/S0034-7450(13)70032-5 |
0.504 |
|
| 2013 |
Lam RW, Parikh SV, Ramasubbu R, Michalak EE, Tam EM, Axler A, Yatham LN, Kennedy SH, Manjunath CV. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 203: 358-65. PMID 24029535 DOI: 10.1192/Bjp.Bp.112.125237 |
0.501 |
|
| 2013 |
McIntyre RS, Alsuwaidan M, Soczynska JK, Szpindel I, Bilkey TS, Almagor D, Woldeyohannes HO, Powell AM, Cha DS, Gallaugher LA, Kennedy SH. The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder Human Psychopharmacology. 28: 421-427. PMID 24014142 DOI: 10.1002/Hup.2325 |
0.359 |
|
| 2013 |
Rizvi SJ, Kennedy SH. Psychopharmacology for the Clinician Journal of Psychiatry & Neuroscience. 38. PMID 23972007 DOI: 10.1503/Jpn.130076 |
0.303 |
|
| 2013 |
Rizvi SJ, Salomons TV, Konarski JZ, Downar J, Giacobbe P, McIntyre RS, Kennedy SH. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. Journal of Affective Disorders. 151: 573-81. PMID 23948629 DOI: 10.1016/J.Jad.2013.06.050 |
0.409 |
|
| 2013 |
Kennedy SH. A review of antidepressant therapy in primary care: current practices and future directions. The Primary Care Companion to the Journal of Clinical Psychiatry. 15: 0-0. PMID 23930234 DOI: 10.4088/Pcc.12R01420 |
0.495 |
|
| 2013 |
Leen J, Soczynska JK, Gallaugher LA, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Dale RM, Muzina DJ, Kennedy SH, McIntyre RS. The effect of personality dimensions on functional outcomes in mood disorders. Advances in Therapy. 30: 671-83. PMID 23839119 DOI: 10.1007/S12325-013-0042-3 |
0.346 |
|
| 2013 |
Stein DJ, Picarel-Blanchot F, Kennedy SH. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression. Human Psychopharmacology. 28: 151-9. PMID 23532747 DOI: 10.1002/Hup.2294 |
0.457 |
|
| 2013 |
Schaffer A, Parikh SV, Kennedy SH, Milev R, Frey BN, Goldstein BI, Beaulieu S, Alda M, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Bond DJ, et al. Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines. Bipolar Disorders. 15: 338-9. PMID 23521579 DOI: 10.1111/Bdi.12055 |
0.68 |
|
| 2013 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, et al. The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disorders. 15: 58-60. PMID 23339676 DOI: 10.1111/Bdi.12038 |
0.654 |
|
| 2013 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. 15: 1-44. PMID 23237061 DOI: 10.1111/Bdi.12025 |
0.694 |
|
| 2013 |
Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR. The effect of vilazodone on sexual function during the treatment of major depressive disorder. The Journal of Sexual Medicine. 10: 2465-76. PMID 23216998 DOI: 10.1111/Jsm.12004 |
0.326 |
|
| 2013 |
Kennedy SH, Avedisova A, Picarel-Blanchot F, Bodinat CD. P.2.f.022 Efficacy of 3 agomelatine dose regimens versus placebo in major depressive disorder (MDD) patients according to the level of severity at baseline European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70645-X |
0.439 |
|
| 2013 |
Kennedy SH, Avedisova A. 2249 – Efficacy and safety of 3 agomelatine dose regimens (10, 25, 25-50 mg) versus placebo in out-patients suffering from moderate to severe major depressive disorder European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)77113-X |
0.305 |
|
| 2013 |
Downar J, Giacobbe P, Salomons T, Geraci J, Bakker N, Dunlop K, Blumberger D, Daskalakis Z, Kennedy S, Flint A. 1565 – Safety, efficacy, and tolerability of intermittent theta-burst rtms of the dorsomedial prefrontal cortex for refractory major depression European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76570-2 |
0.387 |
|
| 2013 |
Kennedy SH, Placenza FM. Agomelatine in depressive disorders Melatonin and Melatonergic Drugs in Clinical Practice. 275-279. DOI: 10.1007/978-81-322-0825-9_19 |
0.399 |
|
| 2012 |
McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disorders. 14: 697-706. PMID 23107220 DOI: 10.1111/Bdi.12006 |
0.562 |
|
| 2012 |
Soczynska JK, Mansur RB, Brietzke E, Swardfager W, Kennedy SH, Woldeyohannes HO, Powell AM, Manierka MS, McIntyre RS. Novel therapeutic targets in depression: Minocycline as a candidate treatment Behavioural Brain Research. 235: 302-317. PMID 22963995 DOI: 10.1016/J.Bbr.2012.07.026 |
0.41 |
|
| 2012 |
Zhu T, De Luca V, Gallaugher LA, Woldeyohannes HO, Soczynska JK, Szymkowicz S, Muzina DJ, Kennedy SH, McIntyre RS. Admixture analysis of age at onset in major depressive disorder. General Hospital Psychiatry. 34: 686-91. PMID 22898442 DOI: 10.1016/J.Genhosppsych.2012.06.010 |
0.476 |
|
| 2012 |
McIntyre RS, Soczynska JK, Liauw SS, Woldeyohannes HO, Brietzke E, Nathanson J, Alsuwaidan M, Muzina DJ, Taylor VH, Cha DS, Kennedy SH. The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project. International Journal of Psychiatry in Medicine. 43: 165-77. PMID 22849038 DOI: 10.2190/Pm.43.2.E |
0.328 |
|
| 2012 |
Parikh SV, Zaretsky A, Beaulieu S, Yatham LN, Young LT, Patelis-Siotis I, Macqueen GM, Levitt A, Arenovich T, Cervantes P, Velyvis V, Kennedy SH, Streiner DL. A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. The Journal of Clinical Psychiatry. 73: 803-10. PMID 22795205 DOI: 10.4088/Jcp.11M07343 |
0.578 |
|
| 2012 |
Kennedy SH, Downar J, Evans KR, Feilotter H, Lam RW, MacQueen GM, Milev R, Parikh SV, Rotzinger S, Soares C. The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Current Pharmaceutical Design. 18: 5976-89. PMID 22681173 DOI: 10.2174/138161212803523635 |
0.638 |
|
| 2012 |
Rizvi SJ, Kennedy SH. Emerging drugs for major depressive disorder: an update. Expert Opinion On Emerging Drugs. 17: 285-294. PMID 22530790 DOI: 10.1517/14728214.2012.681301 |
0.457 |
|
| 2012 |
Harkness KL, Bagby RM, Kennedy SH. Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder. Journal of Consulting and Clinical Psychology. 80: 342-53. PMID 22428942 DOI: 10.1037/A0027665 |
0.499 |
|
| 2012 |
Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, Debonnel G, Sadikot AF, Lam RW, Howard AK, Ilcewicz-Klimek M, Honey CR, Mayberg HS. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. Journal of Neurosurgery. 116: 315-22. PMID 22098195 DOI: 10.3171/2011.10.Jns102122 |
0.457 |
|
| 2012 |
Downar J, Giacobbe P, Salomons T, Geraci J, Wheeler S, Kennedy S, McAndrews MP, Flint A. Dorsomedial prefrontal rTMS for treatment-refractory major depression: safety, tolerability, efficacy, and predictors of clinical response F1000research. 3. DOI: 10.7490/F1000Research.1090444.1 |
0.429 |
|
| 2012 |
Kennedy SH, Cyriac A. A Dimensional Approach to Measuring Antidepressant Response: Implications for Agomelatine Psychology. 3: 864-869. DOI: 10.4236/Psych.2012.310130 |
0.466 |
|
| 2011 |
Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH. Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation International Review of Psychiatry. 23: 424-436. PMID 22200132 DOI: 10.3109/09540261.2011.630993 |
0.434 |
|
| 2011 |
Thase ME, Larsen KG, Kennedy SH. Assessing the ‘true’ effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model British Journal of Psychiatry. 199: 501-507. PMID 22130749 DOI: 10.1192/Bjp.Bp.111.093336 |
0.417 |
|
| 2011 |
Montejo A, Majadas S, Rizvi SJ, Kennedy SH. The effects of agomelatine on sexual function in depressed patients and healthy volunteers Human Psychopharmacology-Clinical and Experimental. 26: 537-542. PMID 22102540 DOI: 10.1002/Hup.1243 |
0.364 |
|
| 2011 |
Rizvi SJ, Kennedy SH. The keys to improving depression outcomes. European Neuropsychopharmacology. 21. PMID 21924209 DOI: 10.1016/J.Euroneuro.2011.07.002 |
0.479 |
|
| 2011 |
Li M, Soczynska JK, Kennedy SH. Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions. Current Psychiatry Reports. 13: 316-320. PMID 21671010 DOI: 10.1007/S11920-011-0210-6 |
0.472 |
|
| 2011 |
Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M. Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. General Hospital Psychiatry. 33: 157-65. PMID 21596209 DOI: 10.1016/J.Genhosppsych.2011.01.012 |
0.392 |
|
| 2011 |
Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. Journal of Affective Disorders. 132: S14-20. PMID 21575992 DOI: 10.1016/J.Jad.2011.03.047 |
0.552 |
|
| 2011 |
Kennedy SH, Young AH, Blier P. Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. Journal of Affective Disorders. 132: S21-8. PMID 21571374 DOI: 10.1016/J.Jad.2011.03.048 |
0.347 |
|
| 2011 |
Kennedy SH. Improving the clinical effectiveness of antidepressant treatment Journal of Affective Disorders. 132. PMID 21514675 DOI: 10.1016/J.Jad.2011.03.044 |
0.339 |
|
| 2011 |
Kennedy SH, Dugré H, Defoy I. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder. International Clinical Psychopharmacology. 26: 151-8. PMID 21471773 DOI: 10.1097/Yic.0B013E32834309Fc |
0.473 |
|
| 2011 |
Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, Lozano AM. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. The American Journal of Psychiatry. 168: 502-10. PMID 21285143 DOI: 10.1176/Appi.Ajp.2010.10081187 |
0.463 |
|
| 2011 |
Rizvi SJ, Yeung NW, Kennedy SH. Instruments to measure sexual dysfunction in community and psychiatric populations. Journal of Psychosomatic Research. 70: 99-109. PMID 21193105 DOI: 10.1016/J.Jpsychores.2010.05.009 |
0.337 |
|
| 2011 |
Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, McIntyre RS. Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus Neuromolecular Medicine. 13: 93-116. PMID 21165712 DOI: 10.1007/S12017-010-8140-8 |
0.361 |
|
| 2011 |
Kennedy SH, Eisfeld BS. Agomelatine and its therapeutic potential in the depressed patient. Neuropsychiatric Disease and Treatment. 3: 423-8. PMID 19300571 |
0.39 |
|
| 2011 |
Rizvi S, Kennedy SH, Giacobbe P, Mayberg HS, Lozano AM. Subgenual cingulate gyrus deep brain stimulation for refractory major depressive disorder: Differences in fluorodeoxyglucose (FDG)-PET between responders and non-responders F1000research. 2. DOI: 10.7490/F1000Research.1299.1 |
0.423 |
|
| 2011 |
Stein D, Kennedy S. P.2.c.001 Efficacy of the novel antidepressant agomelatine for anxiety symptoms within depression European Neuropsychopharmacology. 21: S383. DOI: 10.1016/S0924-977X(11)70615-0 |
0.309 |
|
| 2010 |
Lipsman N, McIntyre RS, Giacobbe P, Torres C, Kennedy SH, Lozano AM. Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets. Bipolar Disorders. 12: 691-701. PMID 21040286 DOI: 10.1111/J.1399-5618.2010.00868.X |
0.52 |
|
| 2010 |
McIntyre RS, Kennedy SH, Soczynska JK, Nguyen HT, Bilkey TS, Woldeyohannes HO, Nathanson JA, Joshi S, Cheng JS, Benson KM, Muzina DJ. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Primary Care Companion to the Journal of Clinical Psychiatry. 12. PMID 20944770 DOI: 10.4088/Pcc.09M00861Gry |
0.406 |
|
| 2010 |
Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. Current Medical Research and Opinion. 26: 2643-51. PMID 20932222 DOI: 10.1185/03007995.2010.522157 |
0.445 |
|
| 2010 |
McIntyre RS, Woldeyohannes HO, Soczynska JK, Miranda A, Lachowski A, Liauw SS, Grossman T, Lourenco MT, Kim B, Alsuwaidan MT, Kennedy SH. The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder. Advances in Therapy. 27: 828-36. PMID 20878373 DOI: 10.1007/S12325-010-0072-Z |
0.321 |
|
| 2010 |
Kennedy SH, Welsh BR, Fulton K, Soczynska JK, McIntyre RS, O'Donovan C, Milev R, le Melledo JM, Bisserbe JC, Zimmerman M, Martin N. Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 568-76. PMID 20840804 DOI: 10.1177/070674371005500905 |
0.427 |
|
| 2010 |
McIntyre RS, Park KY, Law CW, Sultan F, Adams A, Lourenco MT, Lo AK, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J, Kennedy SH. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. Cns Drugs. 24: 741-53. PMID 20806987 DOI: 10.2165/11533280-000000000-00000 |
0.353 |
|
| 2010 |
Kennedy S. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. The Journal of Sexual Medicine. 7: 3449-3459. PMID 20646181 DOI: 10.1111/J.1743-6109.2010.01938.X |
0.337 |
|
| 2010 |
McIntyre RS, Kenna HA, Nguyen HT, Law CW, Sultan F, Woldeyohannes HO, Adams AK, Cheng JS, Lourenco M, Kennedy SH, Rasgon NL. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Advances in Therapy. 27: 63-80. PMID 20390390 DOI: 10.1007/S12325-010-0011-Z |
0.3 |
|
| 2010 |
Kennedy SH, Rizvi SJ. Agomelatine in the treatment of major depressive disorder Cns Drugs. 24: 479-499. PMID 20192279 DOI: 10.2165/11534420-000000000-00000 |
0.454 |
|
| 2010 |
Quilty LC, Godfrey KM, Kennedy SH, Bagby RM. Harm Avoidance as a Mediator of Treatment Response to Antidepressant Treatment of Patients with Major Depression Psychotherapy and Psychosomatics. 79: 116-122. PMID 20090398 DOI: 10.1159/000276372 |
0.489 |
|
| 2010 |
Rizvi SJ, Kennedy SH, Ravindran LN, Giacobbe P, Eisfeld BS, Mancini D, McIntyre RS. The Relationship between Testosterone and Sexual Function in Depressed and Healthy Men The Journal of Sexual Medicine. 7: 816-825. PMID 19796059 DOI: 10.1111/J.1743-6109.2009.01504.X |
0.389 |
|
| 2010 |
Kennedy SH. SS01-03 - More complete and sustained remission: the key to success in depression European Psychiatry. 25: 1694. DOI: 10.1016/S0924-9338(10)71673-4 |
0.429 |
|
| 2010 |
Ravindran AV, Lam RW, Filteau MJ, Lesperance F, Kennedy SH, Parikh SV. B2 Complementary and alternative treatments for depression Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.01.066 |
0.497 |
|
| 2010 |
Kennedy SH. CANMAT: Managing depression in bipolar and unipolar patients: Evidence based approaches from CANMAT guidelines Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.01.021 |
0.42 |
|
| 2009 |
McIntyre RS, Muzina DJ, Adams A, Lourenco MT, Law CW, Soczynska JK, Woldeyohannes HO, Nathanson J, Kennedy SH. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. Expert Opinion On Pharmacotherapy. 10: 3061-75. PMID 19954275 DOI: 10.1517/14656560903448837 |
0.521 |
|
| 2009 |
Kennedy SH. Agomelatine: efficacy at each phase of antidepressant treatment. Cns Drugs. 23: 41-47. PMID 19708725 DOI: 10.2165/11318660-000000000-00000 |
0.461 |
|
| 2009 |
Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. Journal of Affective Disorders. 117: S1-2. PMID 19682750 DOI: 10.1016/J.Jad.2009.06.043 |
0.467 |
|
| 2009 |
Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders. 117: S15-25. PMID 19682749 DOI: 10.1016/J.Jad.2009.06.042 |
0.438 |
|
| 2009 |
Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. Journal of Affective Disorders. 117: S5-14. PMID 19674796 DOI: 10.1016/J.Jad.2009.06.044 |
0.469 |
|
| 2009 |
Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. Journal of Affective Disorders. 117: S26-43. PMID 19674794 DOI: 10.1016/J.Jad.2009.06.041 |
0.5 |
|
| 2009 |
Ravindran AV, Lam RW, Filteau MJ, Lespérance F, Kennedy SH, Parikh SV, Patten SB. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. Journal of Affective Disorders. 117: S54-64. PMID 19666194 DOI: 10.1016/J.Jad.2009.06.040 |
0.515 |
|
| 2009 |
Kennedy SH, Milev R, Giacobbe P, Ramasubbu R, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. Journal of Affective Disorders. 117: S44-53. PMID 19656575 DOI: 10.1016/J.Jad.2009.06.039 |
0.522 |
|
| 2009 |
Kennedy SH, Rizvi SJ. Emerging drugs for major depressive disorder. Expert Opinion On Emerging Drugs. 14: 439-453. PMID 19637989 DOI: 10.1517/14728210903107751 |
0.458 |
|
| 2009 |
Lourenco MTC, Kennedy SH. Desvenlafaxine in the treatment of major depressive disorder Neuropsychiatric Disease and Treatment. 5: 127-136. PMID 19557107 DOI: 10.2147/Ndt.S3360 |
0.358 |
|
| 2009 |
Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. Journal of Clinical Psychopharmacology. 29: 157-164. PMID 19512977 DOI: 10.1097/Jcp.0B013E31819C76E9 |
0.377 |
|
| 2009 |
Hamani C, Mayberg H, Snyder B, Giacobbe P, Kennedy S, Lozano AM. Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting. Journal of Neurosurgery. 111: 1209-15. PMID 19480538 DOI: 10.3171/2008.10.Jns08763 |
0.4 |
|
| 2009 |
Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression? Neurotoxicology. 30: 497-521. PMID 19477018 DOI: 10.1016/J.Neuro.2009.03.004 |
0.373 |
|
| 2009 |
Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry & Neuroscience : Jpn. 34: 175-80. PMID 19448846 |
0.329 |
|
| 2009 |
Levitan RD, Atkinson L, Pedersen R, Buis T, Kennedy SH, Chopra K, Leung EM, Segal ZV. A novel examination of atypical major depressive disorder based on attachment theory. The Journal of Clinical Psychiatry. 70: 879-87. PMID 19422755 DOI: 10.4088/Jcp.07M03306 |
0.489 |
|
| 2009 |
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders. 11: 225-55. PMID 19419382 DOI: 10.1111/J.1399-5618.2009.00672.X |
0.627 |
|
| 2009 |
Chopra KK, Ravindran A, Kennedy SH, Mackenzie B, Matthews S, Anisman H, Bagby RM, Farvolden P, Levitan RD. Sex differences in hormonal responses to a social stressor in chronic major depression. Psychoneuroendocrinology. 34: 1235-41. PMID 19386421 DOI: 10.1016/J.Psyneuen.2009.03.014 |
0.347 |
|
| 2009 |
Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Current Medical Research and Opinion. 25: 161-75. PMID 19210149 DOI: 10.1185/03007990802622726 |
0.472 |
|
| 2009 |
Rizvi S, Kennedy S, McNeely H, Giacobbe P, Mayberg H, Lozano A. P.2.a.049 Functional outcome after 12 months of deep brain stimulation for treatment resistant major depressive disorder European Neuropsychopharmacology. 19: S388-S389. DOI: 10.1016/S0924-977X(09)70598-X |
0.447 |
|
| 2008 |
Chopra KK, Segal ZV, Buis T, Kennedy SH, Levitan RD. Investigating associations between cortisol and cognitive reactivity to sad mood provocation and the prediction of relapse in remitted major depression. Asian Journal of Psychiatry. 1: 33-6. PMID 23050993 DOI: 10.1016/J.Ajp.2008.09.006 |
0.443 |
|
| 2008 |
Kennedy SH. Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. 10: 271-7. PMID 18979940 |
0.371 |
|
| 2008 |
Giacobbe P, Mcintyre RS, Goldstein BI, Kennedy SH, Flint AJ. Rates and patterns of treatment seeking by individuals with mood and anxiety disorders. Psychiatric Services. 59: 1099-1099. PMID 18832492 DOI: 10.1176/Appi.Ps.59.10.1099 |
0.424 |
|
| 2008 |
Kennedy S. Treating each and every depressed patient. Journal of Psychopharmacology. 22: 19-23. PMID 18753279 DOI: 10.1177/0269881108093270 |
0.502 |
|
| 2008 |
Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry. 64: 461-7. PMID 18639234 DOI: 10.1016/j.biopsych.2008.05.034 |
0.317 |
|
| 2008 |
McIntyre RS, Soczynska JK, Mancini D, Lam C, Woldeyohannes HO, Moon S, Konarski JZ, Kennedy SH. The relationship between childhood abuse and suicidality in adult bipolar disorder. Violence & Victims. 23: 361-372. PMID 18624100 DOI: 10.1891/0886-6708.23.3.361 |
0.376 |
|
| 2008 |
Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 361-70. PMID 18616856 DOI: 10.1177/070674370805300605 |
0.447 |
|
| 2008 |
Neimat JS, Hamani C, Giacobbe P, Merskey H, Kennedy SH, Mayberg HS, Lozano AM. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. The American Journal of Psychiatry. 165: 687-93. PMID 18519534 DOI: 10.1176/Appi.Ajp.2008.07081298 |
0.395 |
|
| 2008 |
Soczynska JK, Kennedy SH, Chow CSM, Woldeyohannes HO, Konarski JZ, McIntyre RS. Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders? Expert Opinion On Investigational Drugs. 17: 827-843. PMID 18491985 DOI: 10.1517/13543784.17.6.827 |
0.321 |
|
| 2008 |
Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. Journal of Clinical Psychopharmacology. 28: 329-333. PMID 18480691 DOI: 10.1097/Jcp.0B013E318172B48C |
0.417 |
|
| 2008 |
McNeely HE, Mayberg HS, Lozano AM, Kennedy SH. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. The Journal of Nervous and Mental Disease. 196: 405-10. PMID 18477883 DOI: 10.1097/Nmd.0B013E3181710927 |
0.366 |
|
| 2008 |
Ravindran AV, Kennedy SH, O'Donovan MC, Fallu A, Camacho F, Binder CE. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Psychiatry. 69: 87-94. PMID 18312042 DOI: 10.4088/Jcp.V69N0112 |
0.433 |
|
| 2008 |
Ravindran LN, Eisfeld BS, Kennedy SH. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function. Journal of Clinical Psychopharmacology. 28: 107-108. PMID 18204355 DOI: 10.1097/Jcp.0B013E318160D609 |
0.356 |
|
| 2008 |
Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disorders. 10: 1-37. PMID 18199239 DOI: 10.1111/J.1399-5618.2008.00435.X |
0.456 |
|
| 2008 |
Quilty LC, De Fruyt F, Rolland JP, Kennedy SH, Rouillon PF, Bagby RM. Dimensional personality traits and treatment outcome in patients with major depressive disorder. Journal of Affective Disorders. 108: 241-50. PMID 18067975 DOI: 10.1016/J.Jad.2007.10.022 |
0.456 |
|
| 2008 |
McIntyre R, Wilkins K, Gilmour H, Soczynska J, Konarksi J, Miranda A, Woldeyohannes H, Vagic D, Alsuwaiden M, Kennedy S. The effect of bipolar I disorder and major depressive disorder on workforce function Chronic Diseases in Canada. 28: 84-91. DOI: 10.24095/HPCDP.28.3.01 |
0.346 |
|
| 2008 |
Sadikot AF, Mayberg HS, Lozano AM, Kennedy SH, Giacobbe P, Hamani C, Debonnel G, Kolivakis T, Honey C, Lam R, Howard A. Deep Brain Stimulation for Major Depressive Disorder Resistant to Four or More Treatments Neurosurgery. 62: 1419. DOI: 10.1227/01.Neu.0000333512.42087.34 |
0.462 |
|
| 2008 |
Kalali A, Vaccarino A, Evans K, Kennedy S, Kobak K, Sills T, Sheehan D, Williams J, Greist J, Schatzberg A. P.2.a.010 The depression inventory development workgroup: results from the second validation study European Neuropsychopharmacology. 18: S298. DOI: 10.1016/S0924-977X(08)70399-7 |
0.424 |
|
| 2008 |
Levitan⁎ R, Chopra K, Buis T, Pederson R, Kennedy S, Segal Z. High pre-challenge cortisol levels predict 18 month relapse in remitted depressed patients with recurrent episodes Journal of Affective Disorders. 107: S63. DOI: 10.1016/J.Jad.2007.12.028 |
0.424 |
|
| 2007 |
McIntyre RS, Soczynska JK, Mancini D, Woldeyohannes HO, Konarski JZ, Kennedy SH. Comparing features of bipolar disorder to major depressive disorder in a tertiary mood disorders clinic. Annals of Clinical Psychiatry. 19: 313-317. PMID 18058288 DOI: 10.1080/10401230701653617 |
0.452 |
|
| 2007 |
Kennedy SH, Giacobbe P. Treatment resistant depression--advances in somatic therapies. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 279-287. PMID 18058285 DOI: 10.1080/10401230701675222 |
0.502 |
|
| 2007 |
Konarski JZ, Mcintyre RS, Soczynska JK, Kennedy SH. Neuroimaging Approaches in Mood Disorders: Technique and Clinical Implications Annals of Clinical Psychiatry. 19: 265-277. PMID 18058284 DOI: 10.1080/10401230701653435 |
0.374 |
|
| 2007 |
McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A, Fulgosi D, Kennedy SH. Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 257-64. PMID 18058283 DOI: 10.1080/10401230701653377 |
0.339 |
|
| 2007 |
McIntyre RS, McElroy SL, Konarski JZ, Soczynska JK, Bottas A, Castel S, Wilkins K, Kennedy SH. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. The Journal of Clinical Psychiatry. 68: 1352-1357. PMID 17915973 DOI: 10.4088/Jcp.V68N0905 |
0.335 |
|
| 2007 |
McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, Miranda A, Fulgosi D, Konarski JZ, Kennedy SH. Thiazolidinediones: novel treatments for cognitive deficits in mood disorders? Expert Opinion On Pharmacotherapy. 8: 1615-28. PMID 17685880 DOI: 10.1517/14656566.8.11.1615 |
0.588 |
|
| 2007 |
Kennedy SH. Review: response to SSRIs in unipolar depression occurs in the first week of treatment. Evidence-Based Mental Health. 10: 81-81. PMID 17652563 DOI: 10.1136/Ebmh.10.3.81 |
0.46 |
|
| 2007 |
McIntyre RS, Konarski JZ, Kennedy SH, Dickens SE, Bagby RM. Measuring depressive symptoms in the naturalistic primary-care setting. International Journal of Clinical Practice. 61: 1278-82. PMID 17590219 DOI: 10.1111/J.1742-1241.2007.01448.X |
0.432 |
|
| 2007 |
Konarski JZ, Kennedy SH, McIntyre RS, Rafi-Tari S, Soczynska JK, Mayberg HS. Relationship between regional brain metabolism, illness severity and age in depressed subjects. Psychiatry Research. 155: 203-10. PMID 17574393 DOI: 10.1016/J.Pscychresns.2007.02.001 |
0.478 |
|
| 2007 |
Fresco DM, Segal ZV, Buis T, Kennedy S. Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. Journal of Consulting and Clinical Psychology. 75: 447-55. PMID 17563161 DOI: 10.1037/0022-006X.75.3.447 |
0.306 |
|
| 2007 |
McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Current Opinion in Psychiatry. 20: 406-16. PMID 17551358 DOI: 10.1097/Yco.0B013E3281938102 |
0.342 |
|
| 2007 |
Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American Journal of Psychiatry. 164: 778-88. PMID 17475737 DOI: 10.1176/ajp.2007.164.5.778 |
0.35 |
|
| 2007 |
Castel S, Rush B, Kennedy S, Fulton K, Toneatto T. Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a self-assessment instrument. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 22-7. PMID 17444075 DOI: 10.1177/070674370705200105 |
0.343 |
|
| 2007 |
Mcintyre RS, Konarski JZ, Soczynska JK, Kennedy SH. Residual anxiety symptoms in depressed primary care patients. Journal of Psychiatric Practice. 13: 125-128. PMID 17414691 DOI: 10.1097/01.Pra.0000265772.26627.99 |
0.477 |
|
| 2007 |
Ravindran L, Kennedy SH. Are antidepressants as effective as claimed? Yes, but.... The Canadian Journal of Psychiatry. 52: 98-99. PMID 17375865 DOI: 10.1177/070674370705200205 |
0.508 |
|
| 2007 |
McBride C, Segal Z, Kennedy S, Gemar M. Changes in autobiographical memory specificity following cognitive behavior therapy and pharmacotherapy for major depression. Psychopathology. 40: 147-52. PMID 17318006 DOI: 10.1159/000100003 |
0.34 |
|
| 2007 |
McIntyre RS, McElroy SL, Konarski JZ, Soczynska JK, Wilkins K, Kennedy SH. Problem gambling in bipolar disorder: results from the Canadian Community Health Survey. Journal of Affective Disorders. 102: 27-34. PMID 17240457 DOI: 10.1016/J.Jad.2006.12.005 |
0.374 |
|
| 2007 |
Kennedy SH. Agomelatine: an antidepressant with a novel mechanism of action Future Neurology. 2: 145-151. DOI: 10.2217/14796708.2.2.145 |
0.477 |
|
| 2007 |
Thase M, Kennedy S. P.2.c.003 All for one or one for all - assessing the true treatment effect of active vs placebo therapy in severe major depressive disorder European Neuropsychopharmacology. 17: S342-S343. DOI: 10.1016/S0924-977X(07)70495-9 |
0.354 |
|
| 2007 |
Kennedy S. Requires severe depression a specific treatment? European Psychiatry. 22: S90. DOI: 10.1016/j.eurpsy.2007.01.1170 |
0.363 |
|
| 2006 |
Kennedy SH. Current treatment options: relief of symptoms and ultimate recovery International Journal of Psychiatry in Clinical Practice. 10: 22-26. PMID 24931540 DOI: 10.1080/13651500600552503 |
0.482 |
|
| 2006 |
Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders. 8: 721-39. PMID 17156158 DOI: 10.1111/J.1399-5618.2006.00432.X |
0.619 |
|
| 2006 |
McIntyre RS, Soczynska JK, Bottas A, Bordbar K, Konarski JZ, Kennedy SH. Anxiety disorders and bipolar disorder: a review Bipolar Disorders. 8: 665-676. PMID 17156153 DOI: 10.1111/J.1399-5618.2006.00355.X |
0.414 |
|
| 2006 |
Giacobbe P, Kennedy SH. Deep brain stimulation for treatment-resistant depression: a psychiatric perspective. Current Psychiatry Reports. 8: 437-444. PMID 17094923 DOI: 10.1007/S11920-006-0048-5 |
0.47 |
|
| 2006 |
McIntyre RS, Konarski JZ, Wilkins K, Soczynska JK, Kennedy SH. Obesity in Bipolar Disorder and Major Depressive Disorder: Results from a National Community Health Survey on Mental Health and Well-Being: The Canadian Journal of Psychiatry. 51: 274-280. PMID 16986816 DOI: 10.1177/070674370605100502 |
0.427 |
|
| 2006 |
McIntyre RS, Mancini D, Eisfeld BS, Soczynska JK, Grupp L, Konarski JZ, Kennedy SH. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology. 31: 1029-1035. PMID 16908107 DOI: 10.1016/J.Psyneuen.2006.06.005 |
0.461 |
|
| 2006 |
Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry. 63: 749-55. PMID 16818864 DOI: 10.1001/Archpsyc.63.7.749 |
0.514 |
|
| 2006 |
McIntyre RS, Soczynska JK, Lewis GF, MacQueen GM, Konarski JZ, Kennedy SH. Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opinion On Pharmacotherapy. 7: 1305-21. PMID 16805717 DOI: 10.1517/14656566.7.10.1305 |
0.581 |
|
| 2006 |
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opinion On Drug Safety. 5: 523-537. PMID 16774491 DOI: 10.1517/14740338.5.4.523 |
0.34 |
|
| 2006 |
McIntyre RS, Konarski JZ, Wilkins K, Bouffard B, Soczynska JK, Kennedy SH. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache. 46: 973-982. PMID 16732843 DOI: 10.1111/J.1526-4610.2006.00469.X |
0.394 |
|
| 2006 |
Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder Canadian Journal of Psychiatry. 51: 234-242. PMID 16629348 DOI: 10.1177/070674370605100405 |
0.407 |
|
| 2006 |
McIntyre RS, Konarski JZ, Mancini DA, Zurowski M, Giacobbe P, Soczynska JK, Kennedy SH. Improving outcomes in depression: a focus on somatic symptoms. Journal of Psychosomatic Research. 60: 279-282. PMID 16516660 DOI: 10.1016/J.Jpsychores.2005.09.010 |
0.395 |
|
| 2006 |
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms Expert Opinion On Drug Safety. 5: 157-168. PMID 16370964 DOI: 10.1517/14740338.5.1.157 |
0.352 |
|
| 2006 |
Kennedy SH, Emsley R. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder European Neuropsychopharmacology. 16: 93-100. PMID 16249073 DOI: 10.1016/J.Euroneuro.2005.09.002 |
0.403 |
|
| 2006 |
Mundt JC, Katzelnick DJ, Kennedy SH, Eisfeld BS, Bouffard BB, Greist JH. Validation of an IVRS version of the MADRS Journal of Psychiatric Research. 40: 243-246. PMID 15979643 DOI: 10.1016/J.Jpsychires.2005.05.002 |
0.364 |
|
| 2006 |
McIntyre RS, Konarski JZ, Kennedy SH. One size fits all Canadian Medical Association Journal. 174: 1133-1134. DOI: 10.1503/Cmaj.1060025 |
0.399 |
|
| 2006 |
Kennedy SH. Book Review: Mood Disorders: The Age of Melancholy: Major Depression and its Social Origins The Canadian Journal of Psychiatry. 51: 678-679. DOI: 10.1177/070674370605101009 |
0.432 |
|
| 2006 |
McIntyre RS, Konarski JZ, Soczynska JK, Wilkins K, Panjwani G, Bouffard B, Bottas A, Kennedy SH. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatric Services. 57: 1140-1144. DOI: 10.1176/Appi.Ps.57.8.1140 |
0.355 |
|
| 2006 |
Lozano A, Mayberg H, Von V, McNeely H, Seminowicz D, Hamani C, Schwalb J, Kennedy S. IV.16 Deep brain stimulation in mood disorders Parkinsonism & Related Disorders. 12: 15-16. DOI: 10.1016/S1353-8020(07)70052-4 |
0.336 |
|
| 2006 |
Montgomery S, Olie J, Kennedy S. P.2.c.017 Antidepressant efficacy of agomelatine in major depressive disorder:meta-analysis of three pivotal studies European Neuropsychopharmacology. 16: S321-S322. DOI: 10.1016/S0924-977X(06)70351-0 |
0.354 |
|
| 2006 |
Kennedy SH. A review of antidepressant treatments today European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70007-4 |
0.476 |
|
| 2005 |
McIntyre RS, Konarski JZ, Mancini DA, Fulton KA, Parikh SV, Grigoriadis S, Grupp LA, Bakish D, Filteau MJ, Gorman C, Nemeroff CB, Kennedy SH. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 173: 1327-34. PMID 16301700 DOI: 10.1503/Cmaj.050786 |
0.46 |
|
| 2005 |
McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 17: 83-93. PMID 16075661 DOI: 10.1080/10401230590932380 |
0.341 |
|
| 2005 |
Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders. 7: 5-69. PMID 15952957 DOI: 10.1111/J.1399-5618.2005.00219.X |
0.626 |
|
| 2005 |
Chopra KK, Bagby RM, Dickens S, Kennedy SH, Ravindran A, Levitan RD. A dimensional approach to personality in atypical depression. Psychiatry Research. 134: 161-7. PMID 15840417 DOI: 10.1016/J.Psychres.2005.02.002 |
0.476 |
|
| 2005 |
Lam RW, Kennedy SH. Using metaanalysis to evaluate evidence: practical tips and traps. The Canadian Journal of Psychiatry. 50: 167-174. PMID 15830827 DOI: 10.1177/070674370505000306 |
0.404 |
|
| 2005 |
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 45: 651-60. PMID 15748841 DOI: 10.1016/J.Neuron.2005.02.014 |
0.472 |
|
| 2005 |
Grigoriadis S, Kennedy SH, Srinivisan J, McIntyre RS, Fulton K. Antidepressant augmentation with raloxifene. Journal of Clinical Psychopharmacology. 25: 96-98. PMID 15643109 DOI: 10.1097/01.Jcp.0000150230.07243.52 |
0.402 |
|
| 2005 |
McIntyre RS, Konarski JZ, Grigoriadis S, Fan NC, Mancini DA, Fulton KA, Stewart DE, Kennedy SH. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. Canadian Medical Association Journal. 172: 57-59. PMID 15632406 DOI: 10.1503/Cmaj.1040517 |
0.437 |
|
| 2005 |
Machado M, Davidian C, Perri D, Mahamed A, Konarski J, Poon J, Mancini D, Mclntyre R, Kennedy S, Einarson T. PMH42 COMPARISON OF SSRI AND SNRI TREATMENT FOR DEPRESSION IN PRIMARY CARE: A NATURALISTIC STUDY Value in Health. 8: A208-A209. DOI: 10.1016/S1098-3015(10)67788-1 |
0.3 |
|
| 2004 |
Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C, Muglia P, Mackenzie B, Tharmalingam S, Kennedy SH, Macciardi F, Kennedy JL. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biological Psychiatry. 56: 665-9. PMID 15522250 DOI: 10.1016/J.Biopsych.2004.08.013 |
0.311 |
|
| 2004 |
Lam RW, Kennedy SH. Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 17S-26S. PMID 15147033 |
0.35 |
|
| 2004 |
Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage. 22: 409-18. PMID 15110034 DOI: 10.1016/J.Neuroimage.2004.01.015 |
0.432 |
|
| 2004 |
Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressant medication compliance. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 106-13. PMID 15065744 DOI: 10.1177/070674370404900205 |
0.449 |
|
| 2004 |
Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry. 61: 34-41. PMID 14706942 DOI: 10.1001/Archpsyc.61.1.34 |
0.483 |
|
| 2004 |
Kennedy SH, Holt A, Baker GB. Monoamine oxidase inhibitors Nordisk Medicin. 65: 209-239. DOI: 10.1007/978-3-642-18500-7_8 |
0.32 |
|
| 2003 |
Kennedy SH, Lam RW. Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics. Bipolar Disorders. 5: 36-47. PMID 14700011 DOI: 10.1111/J.1399-2406.2003.00058.X |
0.52 |
|
| 2003 |
Yatham LN, Kennedy SH, Lam RW. Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics. Bipolar Disorders. 5: 5-6. PMID 14687068 DOI: 10.1111/J.1399-2406.2003.00064.X |
0.413 |
|
| 2003 |
Krüger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biological Psychiatry. 54: 1274-83. PMID 14643095 DOI: 10.1016/S0006-3223(03)00691-7 |
0.371 |
|
| 2003 |
Grigoriadis S, Kennedy SH, Bagby RM. A comparison of antidepressant response in younger and older women. Journal of Clinical Psychopharmacology. 23: 405-407. PMID 12920418 DOI: 10.1097/01.Jcp.0000085415.08426.C6 |
0.395 |
|
| 2003 |
Kennedy SH, Lam RW, Morris B. Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Canadian Family Physician Medecin De Famille Canadien. 49: 489-91. PMID 12729245 |
0.33 |
|
| 2003 |
Kennedy SH, Segal ZV, Cohen NL, Levitan RD, Gemar M, Bagby RM. Lithium carbonate versus cognitive therapy as sequential combination treatment strategies in partial responders to antidepressant medication: an exploratory trial. The Journal of Clinical Psychiatry. 64: 439-44. PMID 12716247 DOI: 10.4088/Jcp.V64N0414 |
0.339 |
|
| 2003 |
Farvolden P, Kennedy SH, Lam RW. Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future. Expert Opinion On Investigational Drugs. 12: 65-86. PMID 12517255 DOI: 10.1517/13543784.12.1.65 |
0.44 |
|
| 2003 |
Meyer JH, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN, Wilson AA, Blak T, Eynan-Harvey R, Goulding VS, Houle S, Links P. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. The American Journal of Psychiatry. 160: 90-9. PMID 12505806 DOI: 10.1176/Appi.Ajp.160.1.90 |
0.317 |
|
| 2002 |
Grigoriadis S, Kennedy SH. Role of estrogen in the treatment of depression American Journal of Therapeutics. 9: 503-509. PMID 12424508 DOI: 10.1097/00045391-200211000-00008 |
0.48 |
|
| 2002 |
Lam RW, Wan DD, Cohen NL, Kennedy SH. Combining antidepressants for treatment-resistant depression: a review. The Journal of Clinical Psychiatry. 63: 685-93. PMID 12197448 DOI: 10.4088/Jcp.V63N0805 |
0.457 |
|
| 2002 |
McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disorders. 4: 207-13. PMID 12180276 DOI: 10.1034/J.1399-5618.2002.01189.X |
0.42 |
|
| 2002 |
Tranter R, O'Donovan C, Chandarana P, Kennedy S. Prevalence and outcome of partial remission in depression. Journal of Psychiatry & Neuroscience : Jpn. 27: 241-7. PMID 12174733 |
0.328 |
|
| 2002 |
Knott V, Mahoney C, Kennedy S, Evans K. EEG correlates of acute and chronic paroxetine treatment in depression. Journal of Affective Disorders. 69: 241-9. PMID 12103473 DOI: 10.1016/S0165-0327(01)00308-1 |
0.43 |
|
| 2002 |
Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. The Journal of Clinical Psychiatry. 63: 181-6. PMID 11926715 DOI: 10.4088/Jcp.V63N0302 |
0.306 |
|
| 2002 |
Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. Journal of Psychiatry & Neuroscience : Jpn. 27: 47-51. PMID 11836976 |
0.32 |
|
| 2002 |
Krüger S, Goldapple K, Kennedy S, Houle S, Mayberg H. Regional cerebral blood flow in bipolar disorder measured with PET: trait effects at rest and after mood induction Bipolar Disorders. 4: 88-88. DOI: 10.1034/J.1399-5618.4.S1.37.X |
0.319 |
|
| 2001 |
Kennedy SH, Eisfeld BS, Meyer JH, Bagby RM. Antidepressants in clinical practice: limitations of assessment methods and drug response. Human Psychopharmacology-Clinical and Experimental. 16: 105-114. PMID 12404605 DOI: 10.1002/Hup.189 |
0.316 |
|
| 2001 |
Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American Journal of Psychiatry. 158: 899-905. PMID 11384897 DOI: 10.1176/Appi.Ajp.158.6.899 |
0.364 |
|
| 2001 |
Knott V, Mahoney C, Kennedy S, Evans K. EEG power, frequency, asymmetry and coherence in male depression. Psychiatry Research. 106: 123-40. PMID 11306251 DOI: 10.1016/S0925-4927(00)00080-9 |
0.324 |
|
| 2001 |
Woodside DB, Garfinkel PE, Lin E, Goering P, Kaplan AS, Goldbloom DS, Kennedy SH. Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community American Journal of Psychiatry. 158: 570-574. PMID 11282690 DOI: 10.1176/Appi.Ajp.158.4.570 |
0.328 |
|
| 2001 |
Fu CH, Reed LJ, Meyer JH, Kennedy S, Houle S, Eisfeld BS, Brown GM. Noradrenergic dysfunction in the prefrontal cortex in depression: an [15O] H2O PET study of the neuromodulatory effects of clonidine. Biological Psychiatry. 49: 317-25. PMID 11239902 DOI: 10.1016/S0006-3223(00)01050-7 |
0.398 |
|
| 2001 |
Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J, Wilson AA, Rafi-Tari S, Mayberg HS, Kennedy SH. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. The American Journal of Psychiatry. 158: 78-85. PMID 11136637 DOI: 10.1176/Appi.Ajp.158.1.78 |
0.326 |
|
| 2001 |
Bagby RM, Gilchrist EJ, Rector NA, Dickens SE, Joffe RT, Levitt A, Levitan RD, Kennedy SH. The stability and validity of the sociotropy and autonomy personality dimensions as measured by the revised personal style inventory Cognitive Therapy and Research. 25: 765-779. DOI: 10.1023/A:1012975524455 |
0.382 |
|
| 2000 |
Knott V, Mahoney C, Kennedy S, Evans K. Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry. 33: 201-5. PMID 11147926 DOI: 10.1055/S-2000-8356 |
0.441 |
|
| 2000 |
Schaffer A, Levitt AJ, Bagby RM, Kennedy SH, Levitan RD, Joffe RT. Suicidal ideation in major depression: Sex differences and impact of comorbid anxiety Canadian Journal of Psychiatry. 45: 822-826. PMID 11143832 DOI: 10.1177/070674370004500906 |
0.474 |
|
| 2000 |
Meyer JH, Swinson R, Kennedy SH, Houle S, Brown GM. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. Psychiatry Research. 98: 133-43. PMID 10821996 DOI: 10.1016/S0925-4927(00)00048-2 |
0.326 |
|
| 2000 |
Cohen NL, Parikh SV, Kennedy SH. Medication compliance in mood disorders: Relevance of the Health Belief Model and other determinants Primary Care Psychiatry. 6: 101-110. DOI: 10.1185/135525700543307 |
0.312 |
|
| 1999 |
Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. Sexual dysfunction before antidepressant therapy in major depression. Journal of Affective Disorders. 56: 201-8. PMID 10701478 DOI: 10.1016/S0165-0327(99)00050-6 |
0.383 |
|
| 1999 |
Kennedy SH, Eisfeld BS. Clinical aspects of depression. Clinical Cornerstone. 1: 1-16. PMID 10682174 DOI: 10.1016/S1098-3597(99)90021-2 |
0.472 |
|
| 1999 |
Bagby RM, Rector NA, Segal ZV, Joffe RT, Levitt AJ, Kennedy SH, Levitan RD. Rumination and distraction in major depression: assessing response to pharmacological treatment. Journal of Affective Disorders. 55: 225-9. PMID 10628892 DOI: 10.1016/S0165-0327(99)00015-4 |
0.5 |
|
| 1999 |
Bagby RM, Levitan RD, Kennedy SH, Levitt AJ, Joffe RT. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry Research-Neuroimaging. 86: 211-216. PMID 10482340 DOI: 10.1016/S0165-1781(99)00041-4 |
0.438 |
|
| 1999 |
Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM, Wilson AA, Kennedy SH. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. The American Journal of Psychiatry. 156: 1029-34. PMID 10401447 DOI: 10.1176/Ajp.156.7.1029 |
0.406 |
|
| 1999 |
Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls. Journal of Affective Disorders. 52: 121-133. PMID 10357025 DOI: 10.1016/S0165-0327(98)00050-0 |
0.426 |
|
| 1999 |
Parikh SV, Lesage AD, Kennedy SH, Goering PN. Depression in Ontario: Under-treatment and factors related to antidepressant use Journal of Affective Disorders. 52: 67-76. PMID 10357019 DOI: 10.1016/S0165-0327(98)00063-9 |
0.477 |
|
| 1999 |
Davis R, McVey G, Heinmaa M, Rockert W, Kennedy S. Sequencing of cognitive-behavioral treatments for bulimia nervosa. International Journal of Eating Disorders. 25: 361-374. PMID 10202647 DOI: 10.1002/(Sici)1098-108X(199905)25:4<361::Aid-Eat1>3.0.Co;2-# |
0.33 |
|
| 1999 |
Kennedy SH, Bagby RM, McCann SM, Dickens S, Raskin J. Placebo controlled trials in depression: Bridging ethics and science European Neuropsychopharmacology. 9: 137. DOI: 10.1016/S0924-977X(99)80010-8 |
0.386 |
|
| 1998 |
Krüger S, Mcvey G, Kennedy SH. The Changing Profile Of Anorexia Nervosa At The Toronto Programme For Eating Disorders Journal of Psychosomatic Research. 45: 533-547. PMID 9859855 DOI: 10.1016/S0022-3999(98)00026-9 |
0.321 |
|
| 1998 |
Esplen MJ, Garfinkel PE, Olmsted M, Gallop RM, Kennedy S. A randomized controlled trial of guided imagery in bulimia nervosa Psychological Medicine. 28: 1347-1357. PMID 9854276 DOI: 10.1017/S0033291798007405 |
0.326 |
|
| 1998 |
Levitan RD, Parikh SV, Lesage AD, Hegadoren KM, Adams M, Kennedy SH, Goering PN. Major depression in individuals with a history of childhood physical or sexual abuse: Relationship to neurovegetative features, mania, and gender American Journal of Psychiatry. 155: 1746-1752. PMID 9842786 DOI: 10.1176/Ajp.155.12.1746 |
0.401 |
|
| 1998 |
Meyer JH, Kennedy S, Brown GM. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine. The American Journal of Psychiatry. 155: 1241-6. PMID 9734549 DOI: 10.1176/Ajp.155.9.1241 |
0.416 |
|
| 1998 |
Levitan RD, Kaplan AS, Brown GM, Vaccarino FJ, Kennedy SH, Levitt AJ, Joffe RT. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder. Archives of General Psychiatry. 55: 244-9. PMID 9510218 DOI: 10.1001/Archpsyc.55.3.244 |
0.337 |
|
| 1997 |
Bagby RM, Kennedy SH, Schuller DR, Dickens SE, Minifie CE, Levitt A, Joffe R. Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis. Journal of Affective Disorders. 45: 161-6. PMID 9298429 DOI: 10.1016/S0165-0327(97)00066-9 |
0.41 |
|
| 1997 |
Bagby RM, Kennedy SH, Dickens SE, Minifie CE, Schuller DR. Personality and symptom profiles of the angry hostile depressed patient. Journal of Affective Disorders. 45: 155-60. PMID 9298428 DOI: 10.1016/S0165-0327(97)00065-7 |
0.436 |
|
| 1997 |
Kennedy SH, Javanmard M, Vaccarino FJ. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 467-75. PMID 9220109 DOI: 10.1177/070674379704200502 |
0.463 |
|
| 1997 |
Levitan RD, Lesage A, Parikh SV, Goering P, Kennedy SH. Reversed neurovegetative symptoms of depression: A community study of Ontario American Journal of Psychiatry. 154: 934-940. PMID 9210743 DOI: 10.1176/Ajp.154.7.934 |
0.387 |
|
| 1997 |
Potts AJ, Bennett PJ, Kennedy SH, Vaccarino FJ. Depressive symptoms and alterations in sucrose taste perception: cognitive bias or a true change in sensitivity? Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Expã©Rimentale. 51: 57-60. PMID 9206323 DOI: 10.1037/1196-1961.51.1.57 |
0.42 |
|
| 1997 |
Neitzert CS, Davis C, Kennedy SH. Personality factors related to the prevalence of somatic symptoms and medical complaints in a healthy student population. British Journal of Medical Psychology. 70: 93-101. PMID 9093754 DOI: 10.1111/J.2044-8341.1997.Tb01889.X |
0.399 |
|
| 1997 |
Levitan RD, Kaplan AS, Brown GM, Joffe RT, Levitt AJ, Vaccarino FJ, Kennedy SH. Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression. Biological Psychiatry. 41: 366-8. PMID 9024959 DOI: 10.1016/S0006-3223(96)00432-5 |
0.388 |
|
| 1997 |
Kennedy SH, Bagby RM. Efficacy and effectiveness in the antidepressant treatment of depression: beyond metaanalysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 41: 609-10. PMID 8978937 DOI: 10.1177/070674379604101001 |
0.359 |
|
| 1996 |
Garfinkel PE, Lin E, Goering P, Spegg C, Goldbloom DS, Kennedy S, Kaplan AS, Woodside DB. Purging and nonpurging forms of bulimia nervosa in a community sample International Journal of Eating Disorders. 20: 231-238. PMID 8912035 DOI: 10.1002/(Sici)1098-108X(199611)20:3<231::Aid-Eat2>3.0.Co;2-P |
0.337 |
|
| 1996 |
Kennedy SH, Kutcher SP, Ralevski E, Brown GM. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder Psychiatry Research-Neuroimaging. 63: 219-222. PMID 8878318 DOI: 10.1016/0165-1781(96)02910-1 |
0.364 |
|
| 1995 |
Garfinkel PE, Kennedy SH, Kaplan AS. Views on classification and diagnosis of eating disorders Canadian Journal of Psychiatry. 40: 445-456. PMID 8681268 DOI: 10.1177/070674379504000805 |
0.368 |
|
| 1995 |
Kennedy SH, Katz R, Neitzert CS, Ralevski E, Mendlowitz S. Exposure with response prevention treatment of anorexia nervosa-bulimic subtype and bulimia nervosa Behaviour Research and Therapy. 33: 685-689. PMID 7654160 DOI: 10.1016/0005-7967(95)00011-L |
0.336 |
|
| 1994 |
Kennedy SH, Goldbloom DS. Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa. Cns Drugs. 1: 201-12. PMID 27520519 DOI: 10.2165/00023210-199401030-00005 |
0.388 |
|
| 1994 |
Grof P, Joffe R, Kennedy S, Persad E, Syrotiuk J, Bradford D. An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression. International Clinical Psychopharmacology. 8: 167-72. PMID 8263314 DOI: 10.1097/00004850-199300830-00005 |
0.421 |
|
| 1994 |
Kennedy SH, Kaplan AS, Garfinkel PE, Rockert W, Toner B, Abbey SE. Depression in anorexia nervosa and bulimia nervosa: discriminating depressive symptoms and episodes Journal of Psychosomatic Research. 38: 773-782. PMID 7877132 DOI: 10.1016/0022-3999(94)90030-2 |
0.487 |
|
| 1994 |
Kennedy SH. Melatonin disturbances in anorexia nervosa and bulimia nervosa. International Journal of Eating Disorders. 16: 257-265. PMID 7833959 DOI: 10.1002/1098-108X(199411)16:3<257::Aid-Eat2260160306>3.0.Co;2-3 |
0.343 |
|
| 1994 |
Chouinard G, Saxena BM, Nair NPV, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA, Belanger MC, Snaith J, Beauclair L, Pohlmann H, D'Souza J. A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. Journal of Affective Disorders. 32: 105-114. PMID 7829762 DOI: 10.1016/0165-0327(94)90068-X |
0.407 |
|
| 1994 |
Ramasubbu R, Kennedy SH. Factors complicating the diagnosis of depression in cerebrovascular disease, Part I--Phenomenological and nosological issues. The Canadian Journal of Psychiatry. 39: 596-600. PMID 7828111 DOI: 10.1177/070674379403901003 |
0.455 |
|
| 1994 |
Ramasubbu R, Kennedy SH. Factors complicating the diagnosis of depression in cerebrovascular disease, Part II--Neurological deficits and various assessment methods. The Canadian Journal of Psychiatry. 39: 601-607. PMID 7530165 DOI: 10.1177/070674379403901004 |
0.458 |
|
| 1992 |
Kennedy SH, Brown GM. Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output Psychiatry Research. 43: 177-185. PMID 1410073 DOI: 10.1016/0165-1781(92)90132-M |
0.458 |
|
| 1991 |
Levitt AJ, Brown GM, Kennedy SH, Stern K. Tryptophan treatment and melatonin response in a patient with seasonal affective disorder. Journal of Clinical Psychopharmacology. 11: 74-5. PMID 2040722 DOI: 10.1097/00004714-199102000-00022 |
0.376 |
|
| 1991 |
Kennedy SH, Groot JD, Ralevski E, Reed K. A comparison of adinazolam and desipramine in the treatment of major depression International Clinical Psychopharmacology. 6: 65-76. PMID 1960382 DOI: 10.1097/00004850-199100620-00001 |
0.457 |
|
| 1991 |
Kennedy SH, Goldbloom DS. Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa. Drugs. 41: 367-377. PMID 1711444 DOI: 10.2165/00003495-199141030-00005 |
0.347 |
|
| 1991 |
Kaplan AS, Goldbloom DS, Woodside DB, Swinson RP, Kennedy SH, Rakowski H. Mitral valve prolapse in eating and panic disorder: A pilot study International Journal of Eating Disorders. 10: 531-537. DOI: 10.1002/1098-108X(199109)10:5<531::Aid-Eat2260100505>3.0.Co;2-H |
0.392 |
|
| 1990 |
Kennedy SH, Brown GM, Garfinkel PE, McVey G, Costa D, Parienti V. Sulphatoxy melatonin: an index of depression in anorexia nervosa and bulimia nervosa. Psychiatry Research-Neuroimaging. 32: 221-227. PMID 2388965 DOI: 10.1016/0165-1781(90)90027-3 |
0.343 |
|
| 1990 |
Kennedy SH, McVey G, Katz R. Personality disorders in anorexia nervosa and bulimia nervosa. Journal of Psychiatric Research. 24: 259-269. PMID 2266514 DOI: 10.1016/0022-3956(90)90015-I |
0.355 |
|
| 1990 |
Abbey SE, Toner BB, Garfinkel PE, Kennedy SH, Kaplan AS. Self-report symptoms that predict major depression in patients with prominent physical symptoms International Journal of Psychiatry in Medicine. 20: 247-258. PMID 2265887 DOI: 10.2190/2Ev1-9Tdq-B61C-5Quv |
0.443 |
|
| 1989 |
Kennedy SH, Garfinkel PE, Parienti V, Costa D, Brown GM. Changes in melatonin levels but not cortisol levels are associated with depression in patients with eating disorders. Archives of General Psychiatry. 46: 73-78. PMID 2910222 DOI: 10.1001/Archpsyc.1989.01810010075010 |
0.402 |
|
| 1989 |
Ennis J, Barnes RA, Kennedy S, Trachtenberg DD. Depression in self-harm patients. British Journal of Psychiatry. 154: 41-47. PMID 2775974 DOI: 10.1192/Bjp.154.1.41 |
0.473 |
|
| 1989 |
Kennedy SH, Garfinkel PE, Brown GM. Melatonin and sulphatoxymelatonin in eating disorder patients. British Journal of Psychiatry. 154: 272-273. PMID 2775968 DOI: 10.1192/S0007125000226226 |
0.325 |
|
| 1989 |
Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient Journal of Nervous and Mental Disease. 177: 300-303. PMID 2708973 DOI: 10.1097/00005053-198905000-00009 |
0.448 |
|
| 1989 |
Kennedy SH, Joffe RT. Pharmacological management of refractory depression. The Canadian Journal of Psychiatry. 34: 451-456. PMID 2670176 DOI: 10.1177/070674378903400517 |
0.475 |
|
| 1988 |
Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. A trial of isocarboxazid in the treatment of bulimia nervosa. Journal of Clinical Psychopharmacology. 8: 391-6. PMID 3069879 |
0.319 |
|
| 1988 |
Kennedy S. Book Review: Eating Disorders The Canadian Journal of Psychiatry. 33: 163-164. DOI: 10.1177/070674378803300222 |
0.312 |
|
| 1988 |
Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. A trial of isocarboxazid in the treatment of bulimia nervosa. Journal of Clinical Psychopharmacology. 8: 391-396. DOI: 10.1097/00004714-198812000-00002 |
0.431 |
|
| 1988 |
Piran N, Lerner P, Garfinkel PE, Kennedy SH, Brouillette C. Personality disorders in anorexic patients International Journal of Eating Disorders. 7: 589-599. DOI: 10.1002/1098-108X(198809)7:5<589::Aid-Eat2260070502>3.0.Co;2-H |
0.334 |
|
| 1987 |
Craven JL, Rodin GM, Johnson L, Kennedy SH. The diagnosis of major depression in renal dialysis patients. Psychosomatic Medicine. 49: 482-492. PMID 3671637 DOI: 10.1097/00006842-198709000-00005 |
0.458 |
|
| 1985 |
Ennis J, Barnes RA, Kennedy S. The dexamethasone suppression test and suicidal patients. British Journal of Psychiatry. 147: 419-423. PMID 4075031 DOI: 10.1192/Bjp.147.4.419 |
0.379 |
|
| 1985 |
Kennedy SH, Piran N, Garfinkel PE. Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. Journal of Clinical Psychopharmacology. 5: 279-85. PMID 3862680 DOI: 10.1097/00004714-198510000-00005 |
0.362 |
|
| 1985 |
Piran N, Kennedy S, Garfinkel PE, Owens M. Affective disturbance in eating disorders. The Journal of Nervous and Mental Disease. 173: 395-400. PMID 3859581 |
0.372 |
|
| 1985 |
Wiener J, Kennedy S. Akinesia and mutism following a methylphenidate challenge test. Journal of Clinical Psychopharmacology. 5: 231-233. DOI: 10.1097/00004714-198508000-00008 |
0.409 |
|
| 1984 |
Roy A, Kennedy S. Risk factors for depression in Canadians. The Canadian Journal of Psychiatry. 29: 11-13. PMID 6704878 DOI: 10.1177/070674378402900103 |
0.459 |
|
| 1983 |
Roy A, Thompson R, Kennedy S. Depression in chronic schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 142: 465-70. PMID 6871560 DOI: 10.1192/Bjp.142.5.465 |
0.483 |
|
| Show low-probability matches. |